Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"				"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	15.0	35.1	13.4	22.0	16.6	19.9	16.5	19.2	18.4	17.6	16.4	22.6	20.9	15.4	19.3	26.1	18.2	25.3	19.4	20.7	13.2	11.8	20.4	26.0	13.4	23.4	19.3	10.1	19.7	27.3	33.1	27.3	23.6	15.8	17.3	19.3	21.5	22.8	18.5	19.7	22.2	17.5	21.2	16.4	22.0	19.1	26.6	19.5	39.1	19.5	24.6	24.4	17.2	16.9	15.3	17.2	8.2	14.7	10.0	16.7	10.1	10.1	30.9	24.2	14.8	11.5	14.0	15.5	11.6	12.6	29.2	16.9	21.0	21.6	24.4	20.0	14.7	14.8	42.1	31.0	17.3	15.4	27.2	19.8	13.7	21.1	11.7	17.5	15.0	13.3	15.6	19.4	18.9	23.0	26.2	28.3	14.1	32.9	27.4	18.1	16.6	21.6	27.0	16.1	27.3	20.7	8.4	13.0	16.5	8.5	19.4	9.0	24.8	15.3	10.4	13.9	21.1	11.0	12.2	12.7	16.0	22.1	11.2	15.2	16.0	1.2	12.1	8.2	13.7	14.0	16.5	15.2	12.3	12.6	13.7	15.3	16.7	16.2	1.1	10.0	14.7	17.2	12.6	10.1	13.4	16.6	19.2	18.4	13.2	11.8	19.3	10.1	15.8	19.5
ADGRG5	"GPR114, PGR27"	ENSG00000159618	"Adhesion G protein-coupled receptor G5"	Q8IZF4	16	57542421-57591681	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 37.7;lymphoid tissue: 25.6"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 37.7"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"thalamus: 0.4"	"Low region specificity"	"Detected in single"			HPA007133	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA007133: AB_1849253"	"unprognostic (6.11e-3)"	"prognostic favourable (4.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.09e-4)"	"unprognostic (3.80e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.69e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.32e-3)"	0.7	0.6	2.4	20.2	2.7	1.4	0.8	0.6	2.1	0.6	2.1	2.5	0.0	4.3	0.5	0.2	1.7	0.8	0.8	0.5	1.6	1.1	0.5	0.6	2.9	12.1	2.6	0.9	0.5	0.4	0.2	0.8	0.0	2.9	1.2	1.7	0.5	4.6	0.8	0.4	0.7	7.5	0.3	3.5	12.8	0.5	1.2	3.5	3.4	1.1	0.2	25.6	2.8	0.9	4.0	21.9	37.7	0.0	8.8	11.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.4	2.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	37.7	11.1	0.0	5.6	4.0	1.6	6.4	0.7	2.8	0.4	4.0	0.1	8.8	0.0	21.9	0.0	2.3	2.4	2.7	0.6	2.1	1.6	1.1	2.6	0.9	2.9	3.5
AEN	"FLJ12484, FLJ12562, ISG20L1"	ENSG00000181026	"Apoptosis enhancing nuclease"	Q8WTP8	15	88621296-88632282	"Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048599			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA048599: AB_2756313"	"unprognostic (8.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-2)"	"prognostic favourable (1.72e-4)"	"unprognostic (1.52e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.00e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.10e-2)"	9.4	10.4	6.5	10.2	7.2	14.8	11.2	2.8	5.0	8.0	7.8	4.9	13.4	5.0	9.3	10.2	8.9	7.0	23.0	8.2	4.7	8.5	7.9	17.4	9.1	15.4	13.1	3.1	11.2	18.8	6.7	21.3	11.0	7.8	11.6	9.1	4.3	14.5	9.1	18.8	5.9	8.0	10.6	9.3	14.2	11.1	14.3	4.6	14.0	16.6	10.9	13.7	12.5	5.4	9.3	4.1	0.6	3.6	3.0	15.0	7.6	4.9	22.2	13.9	11.9	6.2	7.5	29.5	17.8	16.3	13.7	16.9	18.2	9.7	21.5	5.7	9.7	7.2	51.2	14.4	11.6	5.2	20.2	11.5	9.0	30.1	15.2	9.5	11.6	9.2	12.7	17.1	14.1	11.4	18.1	12.2	16.7	11.6	11.7	8.0	33.5	12.9	15.4	9.9	15.9	5.7	10.8	11.0	10.1	7.2	8.2	13.7	6.8	10.9	10.4	14.0	19.6	5.7	23.9	23.7	15.9	18.4	12.9	10.7	27.4	0.0	1.8	0.6	5.3	3.1	10.0	9.3	9.1	6.9	4.1	9.3	10.0	8.8	0.4	3.0	3.6	2.4	15.0	7.6	6.5	7.2	2.8	5.0	4.7	8.5	13.1	3.1	7.8	4.6
ARFGAP1	"ARF1GAP, bA261N11.3, FLJ10767"	ENSG00000101199	"ADP ribosylation factor GTPase activating protein 1"	Q8N6T3	20	63272785-63289793	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051019, HPA056273"	Approved		Supported	"Nuclear membrane,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Nuclear membrane"	"HPA051019: AB_2681313, HPA056273: AB_2683084"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.86e-3)"	"unprognostic (8.62e-2)"	"prognostic favourable (4.57e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (3.48e-7)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.86e-1)"	12.3	13.8	17.8	16.7	21.8	12.4	10.4	29.2	28.9	16.0	16.6	27.1	15.3	14.8	17.3	17.9	13.4	16.0	20.0	14.3	17.5	17.2	13.7	14.8	13.1	16.6	26.0	19.9	16.7	32.8	13.7	40.9	17.9	19.2	16.2	11.7	20.1	21.3	18.1	10.4	21.9	15.7	14.8	15.9	17.2	21.1	19.9	22.7	11.2	15.0	10.3	15.5	16.0	11.9	7.4	8.2	8.3	12.6	6.6	9.9	7.0	11.0	21.0	9.2	10.9	11.0	12.5	18.0	16.2	13.4	33.0	16.6	50.0	12.4	8.4	14.9	19.4	15.3	8.3	26.2	10.3	5.5	9.3	6.5	20.3	42.1	16.9	9.8	13.6	10.7	16.9	15.9	9.0	11.6	11.7	9.8	8.8	18.2	17.6	9.2	12.2	18.1	9.9	13.2	8.1	8.1	13.5	9.8	10.8	19.4	20.7	20.2	15.2	12.6	15.0	20.2	27.4	12.2	12.8	10.1	6.5	9.2	20.5	6.9	12.5	6.9	7.6	8.3	8.8	10.5	9.9	4.8	4.8	8.0	8.2	7.4	4.9	4.6	3.6	6.6	12.6	6.2	5.9	7.0	17.8	21.8	29.2	28.9	17.5	17.2	26.0	19.9	19.2	22.7
ARHGAP10	"FLJ20896, FLJ41791, GRAF2"	ENSG00000071205	"Rho GTPase activating protein 10"	A1A4S6	4	147732063-148072780	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	9	"cerebellum: 154.3"	HPA039589			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039589: "	"unprognostic (8.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-2)"	"prognostic favourable (8.15e-5)"	"prognostic unfavourable (6.26e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.09e-2)"	31.2	7.9	2.3	11.3	3.2	2.0	27.8	1.8	3.7	20.1	23.9	1.9	13.2	3.4	15.4	17.6	25.2	17.6	20.3	20.0	2.8	1.6	9.6	4.8	11.8	8.3	3.8	1.9	19.9	7.8	20.8	4.7	7.5	9.9	19.8	6.0	16.0	6.7	17.0	37.5	12.3	8.9	58.0	5.2	9.7	15.9	11.2	2.5	8.7	9.9	12.4	7.9	28.7	24.9	0.0	2.6	14.0	1.5	4.1	9.7	2.1	9.6	3.9	2.1	4.4	16.4	22.4	22.3	13.4	11.2	8.6	6.7	10.1	5.6	0.0	2.3	11.4	4.8	7.8	11.0	10.5	5.3	5.2	3.3	3.1	0.3	25.3	3.2	3.9	11.5	8.6	10.7	9.2	10.4	0.4	18.3	15.4	11.8	2.0	0.0	1.9	1.9	3.7	6.1	11.3	5.9	8.9	5.2	2.4	3.5	14.1	3.7	1.7	0.3	10.4	8.2	6.3	4.9	6.4	6.8	0.8	0.0	12.4	0.4	7.2	0.0	1.5	14.0	5.2	0.0	9.7	0.0	3.9	5.7	2.6	0.0	1.1	5.7	0.2	4.1	0.0	0.0	4.6	2.1	2.3	3.2	1.8	3.7	2.8	1.6	3.8	1.9	9.9	2.5
ARMCX6	"FLJ20811, GASP10"	ENSG00000198960	"Armadillo repeat containing, X-linked 6"	Q7L4S7	X	101615118-101618001	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043030, HPA048125"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane"	"HPA043030: , HPA048125: "	"unprognostic (1.20e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.38e-2)"	15.1	17.2	11.7	12.1	12.1	7.6	12.7	10.9	12.1	18.7	12.0	15.4	22.6	6.7	17.3	25.9	17.3	14.1	12.4	15.6	11.3	12.6	14.1	12.2	11.2	12.1	13.1	10.3	21.3	27.2	23.4	21.0	16.3	13.1	17.7	9.0	11.8	39.2	23.5	6.5	11.3	10.4	17.1	16.7	22.6	10.6	9.0	11.4	17.9	17.3	9.7	19.3	18.8	13.7	12.8	14.1	10.0	7.0	8.1	8.7	6.4	6.6	7.8	12.3	7.0	25.2	15.0	2.4	13.9	13.6	12.5	24.5	4.7	6.4	7.1	14.3	13.0	6.9	11.9	5.6	9.8	6.1	7.3	6.6	10.9	6.2	11.6	6.4	8.4	9.3	5.8	7.7	4.0	12.7	5.4	9.1	18.7	16.3	9.4	0.0	8.8	1.6	9.7	16.5	2.6	9.0	0.9	6.8	6.4	8.2	0.0	10.4	5.7	3.1	9.8	15.3	6.9	21.2	3.2	11.3	6.0	0.0	4.5	1.7	5.0	10.0	3.8	6.3	6.5	7.0	8.7	12.8	7.0	7.3	8.1	9.1	8.4	7.8	0.5	8.1	5.0	14.1	3.9	6.4	11.7	12.1	10.9	12.1	11.3	12.6	13.1	10.3	13.1	11.4
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665734	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 32.0;stomach 1: 85.8"	"Cell line enriched"	"Detected in some"	9	"RT4: 41.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: "	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.2	0.0	0.5	10.3	0.3	0.0	7.5	0.2	0.3	1.0	7.9	0.6	0.2	2.2	0.3	3.3	0.6	0.4	32.0	0.2	0.2	0.1	2.5	0.2	13.0	0.2	0.2	0.2	0.2	8.0	0.0	0.2	0.8	0.2	4.6	9.9	0.2	4.6	0.3	0.3	1.5	4.0	3.2	0.2	0.2	85.8	0.4	0.2	0.3	0.2	1.5	1.2	15.1	3.9	0.4	0.0	1.1	0.0	0.0	1.4	1.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	2.4	0.0	0.0	0.0	4.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.9	41.1	0.6	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.9	0.7	0.0	0.0	0.1	1.4	1.1	0.0	0.0	0.0	0.0	1.5	0.5	0.3	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2
CCDC125	KENAE	ENSG00000183323	"Coiled-coil domain containing 125"	Q86Z20	5	69280175-69332809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 5.8;eosinophil: 13.0;neutrophil: 10.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA041878	Approved		Uncertain	"Nucleoplasm,Nuclear membrane,Intermediate filaments"				"Nuclear membrane, Intermediate filaments"	Nucleoplasm	"HPA041878: AB_10796787"	"prognostic unfavourable (8.06e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-2)"	"prognostic favourable (4.40e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"prognostic favourable (2.51e-4)"	4.3	6.1	4.9	6.1	5.6	13.6	10.0	4.9	4.7	4.1	7.9	5.8	7.8	6.7	5.9	4.0	6.6	5.5	10.0	3.0	4.8	4.9	5.0	17.6	5.8	6.2	6.4	4.9	4.8	14.9	4.2	10.4	5.5	6.7	10.1	7.9	3.6	15.9	12.3	2.8	5.3	10.6	4.5	4.7	5.2	8.3	3.4	4.1	3.1	5.5	4.7	5.5	7.3	5.6	0.9	1.5	13.0	2.3	1.1	1.1	0.8	2.1	3.5	0.7	10.0	1.2	0.7	12.8	1.3	1.9	0.8	0.5	3.1	10.7	3.9	7.4	1.4	2.7	7.3	3.7	0.8	13.4	5.8	2.4	5.7	6.0	3.1	2.6	1.4	4.1	1.9	4.1	1.3	1.4	7.1	1.7	0.7	8.6	3.4	4.2	0.1	2.3	4.9	0.0	5.2	4.9	2.4	4.1	2.6	2.6	5.9	1.9	19.1	2.7	1.6	0.8	1.4	2.5	2.0	7.8	11.9	1.4	2.5	14.3	0.4	5.8	1.1	13.0	1.1	0.9	0.9	0.9	1.0	0.8	1.5	0.9	0.9	0.5	10.9	1.1	2.3	1.2	0.7	0.8	4.9	5.6	4.9	4.7	4.8	4.9	6.4	4.9	6.7	4.1
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404786	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 96.6"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 111.2;TIME: 95.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"			1000000000	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	48.7	5.6	4.0	6.2	5.8	0.6	28.1	2.6	4.8	11.1	6.6	3.4	5.5	3.7	18.7	11.2	8.4	7.2	12.6	21.7	4.5	4.3	7.8	12.7	43.7	9.7	6.5	2.8	7.7	3.6	5.0	3.5	96.6	7.6	9.0	4.8	8.5	5.2	4.4	19.0	7.0	6.8	12.1	5.4	10.8	5.7	6.7	3.3	1.2	16.6	15.7	4.5	11.7	11.3	0.0	0.6	0.4	0.8	0.1	0.1	1.1	0.0	0.0	0.6	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	111.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	95.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	1.1	4.0	5.8	2.6	4.8	4.5	4.3	6.5	2.8	7.6	3.3
CDIPT	"PIS, PIS1"	ENSG00000103502	"CDP-diacylglycerol--inositol 3-phosphatidyltransferase"	O14735	16	29858357-29863736	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056597	Approved		Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane"				"Nucleoplasm, Nuclear membrane, Plasma membrane"		"HPA056597: "	"unprognostic (7.81e-2)"	"prognostic favourable (9.40e-4)"	"unprognostic (1.93e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.48e-1)"	40.4	40.8	24.3	20.2	28.1	15.3	42.9	50.7	39.5	37.1	37.2	21.5	33.9	24.8	33.4	23.0	39.4	30.1	34.5	44.4	23.1	27.9	34.8	66.3	27.1	22.4	24.1	26.4	52.7	40.0	47.1	24.9	43.7	21.8	36.8	16.1	29.3	42.2	38.8	21.0	29.6	32.6	31.8	21.0	25.6	29.5	20.2	16.4	30.4	47.1	19.9	17.3	41.8	42.8	4.8	6.1	20.6	6.5	8.2	8.4	2.7	12.3	26.8	7.5	15.1	41.3	28.6	22.4	21.7	24.3	15.4	15.4	15.6	23.8	8.3	41.1	25.0	19.5	12.2	14.0	7.1	20.7	24.5	5.9	20.0	22.8	28.8	8.8	15.4	48.3	24.8	20.7	9.5	19.3	8.8	21.5	13.9	39.4	11.9	17.4	18.0	20.0	23.3	9.4	24.1	20.3	11.9	31.2	17.5	11.5	24.5	17.1	18.3	23.9	16.7	22.9	7.2	18.6	11.1	16.0	18.1	5.9	25.0	14.2	13.8	7.5	6.5	20.6	6.9	4.6	4.6	4.7	6.4	7.3	3.0	4.8	6.3	5.9	16.4	8.2	5.7	6.1	8.4	2.7	24.3	28.1	50.7	39.5	23.1	27.9	24.1	26.4	21.8	16.4
CPD	GP180	ENSG00000108582	"Carboxypeptidase D"	O75976	17	30378905-30469989	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HSkMC: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052796, HPA055465"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear speckles"			930000	"Nucleoplasm, Nuclear speckles"	"Nuclear membrane"	"HPA052796: , HPA055465: "	"unprognostic (1.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.25e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.08e-1)"	16.4	8.0	9.8	12.3	12.4	18.1	17.9	9.1	13.3	28.6	16.2	18.5	10.1	12.9	12.6	10.1	10.0	15.2	33.6	10.5	12.8	10.4	13.4	26.8	20.0	14.2	22.1	11.4	7.8	14.7	21.2	14.9	22.3	13.9	11.4	13.3	7.5	59.7	7.9	10.0	7.8	22.0	15.1	25.9	7.9	24.6	25.0	13.5	5.8	37.2	7.7	10.0	11.5	11.6	0.4	3.4	19.3	5.5	2.1	3.8	2.5	12.1	18.5	16.1	16.5	16.8	32.0	5.8	16.8	24.6	11.7	14.4	21.7	7.9	1.5	21.4	19.2	8.7	10.4	21.2	19.7	5.7	14.9	3.4	11.4	13.4	20.4	22.6	9.1	57.0	9.5	14.9	14.5	23.6	6.7	18.0	9.3	2.3	7.2	6.2	4.5	4.2	7.0	18.7	4.7	21.8	13.9	4.0	10.2	20.0	17.3	8.7	16.4	15.7	28.1	11.7	7.7	18.1	16.0	7.2	15.1	5.1	14.9	14.8	9.8	2.8	5.5	6.4	3.4	2.8	3.8	0.2	1.7	2.8	3.4	0.4	1.4	1.7	19.3	2.1	2.3	0.4	1.1	2.5	9.8	12.4	9.1	13.3	12.8	10.4	22.1	11.4	13.9	13.5
CREB3L4	"AIbZIP, ATCE1, CREB3, CREB4, hJAL"	ENSG00000143578	"CAMP responsive element binding protein 3 like 4"	Q8TEY5	1	153967534-153974363	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 49.9"	"Group enriched"	"Detected in many"	4	"MCF7: 24.8;SK-BR-3: 54.8;T-47d: 44.0"	"Group enriched"	"Detected in all"	5	"breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038122	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"				"Nucleoplasm, Nuclear membrane"	Mitochondria	"HPA038122: AB_10669516"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.13e-3)"	"prognostic favourable (7.21e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.34e-3)"	4.3	5.0	3.2	5.4	4.0	2.9	22.6	5.7	3.5	14.6	5.1	4.3	18.3	5.0	8.5	12.1	5.1	8.8	7.9	3.2	2.5	1.4	4.5	8.4	4.7	5.5	3.2	3.0	9.3	7.9	3.7	3.4	6.6	4.0	49.9	6.9	4.7	24.7	11.4	6.1	5.9	5.3	3.4	3.3	4.5	13.2	4.3	3.0	12.9	12.5	6.6	8.3	4.5	15.1	6.6	7.3	2.6	3.5	10.9	6.0	3.1	2.2	3.3	3.1	3.4	2.2	3.2	7.8	1.9	2.2	2.6	2.3	1.5	9.6	4.2	10.1	0.8	3.7	4.6	3.0	1.4	3.4	1.8	3.1	3.5	2.7	1.8	1.4	2.7	3.5	2.9	2.5	5.7	2.3	2.4	5.3	1.2	24.8	2.7	1.1	2.1	4.0	6.1	3.2	7.8	2.8	1.6	5.8	6.3	2.0	54.8	5.2	44.0	4.5	1.4	0.8	2.4	1.6	1.5	9.9	5.1	3.1	1.7	2.5	2.5	2.2	3.5	2.6	4.5	1.5	6.0	6.3	2.6	3.3	6.4	6.6	2.5	4.8	0.1	10.9	2.1	7.3	2.1	3.1	3.2	4.0	5.7	3.5	2.5	1.4	3.2	3.0	4.0	3.0
CRY1	PHLL1	ENSG00000008405	"Cryptochrome circadian regulator 1"	Q16526	12	106991364-107093829	"Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018762	Approved		Supported	"Nucleoplasm,Nuclear membrane,Microtubules"				"Nucleoplasm, Nuclear membrane, Microtubules"		"CAB018762: AB_2083970"	"unprognostic (1.21e-3)"	"unprognostic (4.74e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	12.2	12.2	8.7	8.5	12.6	9.5	18.3	29.2	10.3	12.4	14.3	12.4	5.0	10.7	14.3	12.9	10.7	15.8	16.3	12.2	10.5	8.7	16.0	13.7	18.0	5.0	17.4	7.3	10.7	12.9	8.6	10.0	13.4	13.1	11.2	8.3	8.7	9.4	11.8	10.8	8.7	17.6	15.9	15.4	10.1	14.6	37.6	15.1	26.5	20.1	6.2	7.5	9.5	18.4	1.7	3.5	6.8	6.4	4.7	13.9	4.7	8.5	8.7	10.7	11.8	7.7	4.9	19.2	9.2	9.8	18.7	12.7	10.0	5.2	0.0	5.8	8.5	5.9	13.7	4.7	20.5	8.6	8.5	8.4	7.8	6.9	9.9	8.6	7.4	4.6	4.9	13.7	13.0	15.5	9.4	7.5	11.5	6.0	19.2	9.7	13.1	12.7	17.2	27.1	3.0	13.1	10.1	19.4	10.0	17.3	11.3	5.5	8.0	4.8	6.8	11.0	11.8	7.5	8.1	13.9	13.0	4.0	5.3	8.2	8.9	6.8	2.5	4.4	11.2	3.8	13.9	1.6	8.5	7.0	3.5	1.7	8.0	7.8	1.1	4.7	6.4	2.3	11.0	4.7	8.7	12.6	29.2	10.3	10.5	8.7	17.4	7.3	13.1	15.1
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042299	Approved		Approved	"Nuclear membrane,Nucleoli,Centrosome"	"Secreted - unknown location"			"Nuclear membrane"	"Nucleoli, Centrosome"	"HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favourable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favourable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favourable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favourable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	13.1	17.3	18.7	5.1	26.4	3.6	15.0	20.6	27.5	15.0	8.1	21.8	14.6	13.3	13.9	27.1	9.8	17.4	14.5	10.3	17.8	21.6	22.9	25.3	8.6	7.4	19.7	26.1	19.5	17.0	28.5	18.5	9.9	19.1	12.0	6.8	17.3	17.5	16.8	12.2	11.7	10.3	7.8	21.7	7.9	12.3	54.1	17.1	4.8	20.6	7.1	6.8	12.0	8.6	9.4	13.0	14.7	12.7	5.9	12.5	9.0	7.8	10.5	6.1	6.4	39.3	11.6	2.5	7.6	16.4	5.5	5.7	3.1	5.2	2.5	6.9	8.8	11.1	2.5	3.5	2.2	8.3	12.6	2.4	6.6	5.2	7.1	1.0	4.8	15.1	8.4	3.0	6.0	10.0	2.5	15.5	4.2	9.6	3.6	1.6	2.2	5.7	4.4	5.4	6.2	12.8	4.1	4.9	4.1	8.5	5.0	11.2	13.2	1.5	13.5	8.1	2.1	7.5	3.9	3.0	2.2	1.9	10.0	2.2	3.1	0.6	12.7	14.7	7.2	10.4	8.1	9.4	11.4	8.8	12.0	9.4	10.8	9.7	11.7	5.9	9.4	13.0	12.5	9.0	18.7	26.4	20.6	27.5	17.8	21.6	19.7	26.1	19.1	17.1
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991250-41018398	"Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 137.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: , HPA062973: "	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	3.0	137.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	1.8	3.1	0.8	0.7	0.9	0.1	0.4	0.4	0.5	0.4	0.1	0.0	0.4	0.2	0.4	0.0	0.2	1.6	0.0	0.4	0.3	0.3	7.4	0.4	0.1	0.1	0.3	0.6	0.4	0.8	0.5	0.4	0.4	0.4	0.0	0.5	0.3	0.1	0.6	0.4	0.1	0.2	0.1	0.8	1.9	0.7	0.5	0.2	0.5	0.5	1.8	0.1	0.9	0.2	0.3	0.1	0.5	0.8	1.1	0.9	0.6	0.3	0.8	0.6	0.3	0.8	0.9	0.2	1.2	0.3	3.1	0.8	0.4	0.4	0.5	0.4	0.6	0.6	0.4	0.1	1.9	0.5	0.8	2.7	0.7	0.3	1.8	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487828	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;ovary: 57.1"	"Group enriched"	"Detected in some"	6	"AN3-CA: 29.4;HeLa: 15.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	0.9	2.6	0.5	0.9	4.0	0.2	0.4	0.7	1.2	0.3	0.4	0.5	0.1	0.3	0.6	4.9	0.3	1.7	1.0	1.1	0.1	28.6	1.0	0.7	0.2	1.2	0.3	0.1	57.1	0.6	0.3	8.9	0.4	5.5	0.3	0.2	11.5	0.3	1.2	1.8	0.3	0.3	1.1	4.5	2.0	0.3	0.8	1.6	0.1	0.5	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	0.0	2.6	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.0	0.7	1.2	0.1	28.6	0.3	0.1	5.5	1.6
EOGT	"AER61, C3orf64, FLJ33770"	ENSG00000163378	"EGF domain specific O-linked N-acetylglucosamine transferase"	Q5NDL2	3	68975214-69013961	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019460	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA019460: AB_1844628"	"unprognostic (2.62e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavourable (8.97e-5)"	"unprognostic (7.41e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	14.9	5.8	3.4	10.1	4.4	3.0	11.9	2.5	4.8	16.8	12.1	4.4	10.2	4.8	23.3	10.4	15.1	11.4	18.1	18.2	3.9	3.6	6.6	5.5	15.8	9.6	4.2	5.0	12.7	7.8	3.9	5.5	15.2	5.1	18.9	5.8	8.7	14.0	24.0	28.0	6.1	7.7	29.4	4.9	10.2	10.1	7.4	2.4	8.3	5.4	14.2	7.3	27.0	9.8	1.7	3.4	5.5	2.2	3.3	9.2	1.8	8.1	2.7	5.4	6.5	7.6	14.9	3.9	11.0	13.5	7.0	9.3	3.7	4.6	0.4	1.7	11.9	2.7	3.7	14.3	8.8	26.3	2.6	8.4	6.2	5.2	8.4	4.7	3.5	12.4	12.2	9.0	11.5	38.4	2.3	5.0	23.4	2.1	0.7	1.5	6.2	1.3	0.3	5.6	3.5	6.0	18.7	0.5	3.0	12.6	1.0	10.0	2.8	6.5	20.3	19.7	6.0	2.2	10.6	2.5	8.3	4.0	7.8	7.3	11.0	5.5	2.2	0.0	3.0	1.9	3.5	1.7	4.8	6.4	3.4	1.2	4.1	4.1	0.3	3.3	0.7	0.6	9.2	1.8	3.4	4.4	2.5	4.8	3.9	3.6	4.2	5.0	5.1	2.4
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902852	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.8;liver: 58.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.6;Daudi: 13.2;SH-SY5Y: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 15.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favourable (8.69e-4)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (6.67e-4)"	4.8	5.2	1.3	5.7	4.5	26.8	2.1	0.6	1.1	2.2	5.5	1.2	1.5	7.5	1.8	1.9	3.8	1.3	1.6	1.5	1.6	4.3	7.9	58.2	11.6	6.7	2.9	0.7	1.4	3.2	0.3	2.5	2.5	2.8	2.9	4.0	5.2	2.5	4.7	1.4	2.5	9.1	2.0	1.7	10.0	4.2	3.6	1.1	13.0	2.3	2.0	8.5	2.9	2.5	1.6	3.0	0.4	11.5	2.3	3.2	1.3	1.9	0.6	0.7	3.5	0.0	0.0	11.6	0.0	1.2	0.8	2.2	0.9	0.6	13.2	3.3	0.1	2.0	5.7	0.9	0.0	5.1	4.9	0.3	0.2	1.9	5.6	0.0	1.2	1.4	1.6	1.9	0.0	0.4	0.8	0.0	0.0	6.8	7.1	0.2	1.1	4.5	5.8	1.4	0.0	1.6	2.7	5.8	29.3	2.4	1.5	0.7	5.6	1.6	0.2	0.1	1.9	3.7	2.3	5.6	4.2	3.2	2.4	4.5	0.0	0.0	3.0	0.2	3.0	6.3	2.5	0.8	1.6	2.1	3.0	1.6	3.2	1.8	0.4	2.3	11.5	0.1	2.3	1.3	1.3	4.5	0.6	1.1	1.6	4.3	2.9	0.7	2.8	1.1
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142330-96160792	"Disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.8;placenta: 16.9"	"Cell line enriched"	"Detected in some"	8	"LHCN-M2: 26.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"			Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	2.5	0.2	1.4	1.5	0.9	0.0	0.8	0.1	1.7	0.3	1.4	0.3	1.5	0.6	3.0	0.7	0.8	1.0	6.6	11.8	0.9	1.0	0.4	0.7	0.4	1.9	0.9	0.1	2.2	1.3	0.1	0.3	16.9	1.1	0.6	0.5	2.9	0.1	2.7	0.8	0.0	1.6	1.8	0.2	0.1	1.4	1.1	1.1	0.1	1.4	0.1	0.1	3.2	2.1	0.1	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.5	3.2	2.1	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	26.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.9	0.1	1.7	0.9	1.0	0.9	0.1	1.1	1.1
GRK5	GPRK5	ENSG00000198873	"G protein-coupled receptor kinase 5"	P34947	10	119207589-119459742	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 36.5;HUVEC TERT2: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"				"Nuclear membrane, Nuclear speckles"	"Plasma membrane"	"CAB025579: , HPA046838: "	"unprognostic (1.09e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (2.38e-7)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	15.9	8.3	3.4	16.8	7.8	2.7	10.2	6.5	5.0	12.5	18.8	3.9	4.5	12.4	13.4	12.2	8.1	7.7	19.5	45.4	4.2	4.2	4.3	5.7	27.6	8.8	3.7	2.5	16.5	3.5	26.2	6.3	24.0	4.5	7.5	6.4	5.6	5.0	6.7	12.8	4.7	10.4	10.8	4.8	17.0	13.9	3.5	4.7	9.8	8.9	10.7	8.6	9.5	13.6	9.3	2.2	6.5	3.7	0.2	11.3	4.2	4.0	2.3	6.0	6.1	13.8	13.3	1.8	7.8	36.5	4.9	2.7	1.9	5.9	4.3	1.8	12.2	1.0	2.6	8.6	3.2	17.1	2.1	0.7	5.0	7.7	9.5	0.2	2.2	1.8	1.3	9.8	1.4	28.8	0.4	4.2	1.7	0.6	4.0	3.9	0.9	6.0	1.4	0.8	1.0	0.8	1.6	2.0	5.5	2.7	1.2	7.5	0.1	1.0	8.7	2.6	1.9	15.8	3.0	0.9	4.6	2.6	5.5	4.8	2.5	0.9	3.7	6.5	5.3	3.2	0.4	9.3	7.7	3.8	2.2	9.1	11.3	5.0	5.0	0.2	0.9	0.0	9.2	4.2	3.4	7.8	6.5	5.0	4.2	4.2	3.7	2.5	4.5	4.7
HEY1	"bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1"	ENSG00000164683	"Hes related family bHLH transcription factor with YRPW motif 1"	Q9Y5J3	8	79764010-79767863	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 48.4;PC-3: 11.0;SK-MEL-30: 33.1;WM-115: 11.3"	"Cancer enhanced"	"Detected in all"		"glioma: 43.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055599, HPA063472"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA055599: AB_2682858, HPA063472: "	"unprognostic (1.15e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.71e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.77e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.00e-1)"	13.3	3.8	13.7	3.6	22.9	1.8	8.8	11.2	60.6	8.9	4.4	10.7	0.0	3.3	3.8	2.4	4.6	3.9	5.7	13.4	11.3	11.6	3.8	2.9	16.4	3.3	11.9	9.3	2.6	4.3	3.0	9.9	20.3	12.5	4.5	3.9	10.3	4.5	3.0	10.3	3.5	3.2	4.4	9.1	2.8	3.6	3.9	10.5	1.3	5.0	3.7	3.7	5.2	2.5	0.0	0.0	9.9	1.7	0.0	0.3	0.1	0.6	0.0	0.4	3.4	0.3	0.2	8.8	0.8	0.8	0.1	0.1	0.1	0.0	1.6	0.8	0.3	2.2	1.8	0.1	0.2	0.1	48.4	0.0	1.5	0.8	0.5	0.0	0.3	0.4	1.4	0.0	6.1	1.6	3.1	1.4	0.5	0.1	0.0	0.2	0.1	11.0	0.0	1.8	1.4	0.1	1.5	2.0	5.6	0.0	1.0	33.1	0.0	0.0	1.1	0.2	0.9	0.0	0.6	1.2	0.2	0.0	1.2	0.0	11.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.9	0.0	1.7	0.0	0.0	0.1	13.7	22.9	11.2	12.3	11.3	11.6	11.9	9.3	12.5	10.5
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339823	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;NB-4: 41.4;RPMI-8226: 48.2;U-266/84: 34.1;U-937: 33.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 172.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 172.3"									"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"			370000000	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: "	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	6.8	2.8	1.7	23.5	1.9	51.5	5.5	0.6	1.5	3.0	6.8	1.1	1.2	4.3	1.7	3.0	4.0	2.9	7.2	6.4	1.1	0.9	5.1	28.7	13.2	68.5	1.8	1.4	1.7	6.8	0.2	0.4	4.8	1.5	2.8	3.3	2.4	10.3	1.3	5.0	1.6	11.9	1.8	1.0	39.4	5.4	1.4	1.0	47.6	3.0	5.7	38.4	4.5	4.9	25.5	28.4	172.3	33.5	31.0	41.0	43.1	2.6	1.3	0.9	2.9	1.6	1.3	1.6	1.6	1.1	1.4	1.2	1.1	1.8	0.0	5.7	1.4	1.1	0.0	1.2	0.4	19.8	0.8	5.0	1.2	5.0	0.8	18.3	20.7	1.1	1.0	1.6	0.5	0.6	2.7	64.3	1.5	5.4	2.4	41.4	0.7	9.0	1.5	0.6	48.2	1.4	2.3	0.3	1.2	1.4	4.5	3.6	3.9	5.2	1.1	6.3	0.5	7.0	1.6	3.1	34.1	7.6	4.5	33.8	4.9	15.3	33.1	72.0	33.8	24.4	41.0	25.5	32.7	31.2	28.4	23.9	29.3	27.4	172.3	31.0	33.5	4.8	36.9	43.1	1.7	1.9	0.6	1.5	1.1	0.9	1.8	1.4	1.5	1.0
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 109.4;testis: 101.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 109.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavourable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	8.0	18.5	15.6	25.9	22.2	23.0	8.1	30.7	25.4	9.4	43.3	4.6	7.7	37.5	6.1	5.4	52.8	4.3	23.7	6.1	17.9	19.6	15.5	12.8	13.9	26.3	11.1	15.0	5.6	6.5	1.2	6.6	29.2	13.7	7.0	23.7	3.3	15.9	17.6	23.7	9.3	51.3	7.3	8.3	26.2	42.5	101.3	4.9	32.6	5.8	28.9	28.7	17.9	17.0	15.4	14.5	109.4	28.4	10.2	28.7	14.6	91.6	91.4	48.1	47.7	10.2	10.5	38.4	48.3	14.4	47.5	36.6	74.8	55.0	25.8	31.0	38.6	54.8	44.9	60.1	35.8	25.8	56.4	41.5	36.3	74.0	24.0	31.1	40.1	16.0	28.8	38.6	39.8	86.2	23.4	53.2	43.4	66.4	99.7	30.4	28.0	120.5	63.7	57.5	40.0	50.7	57.6	59.8	48.6	69.1	36.6	25.7	98.1	19.1	49.6	27.2	76.9	38.1	56.0	20.8	33.5	38.6	23.7	29.2	31.0	27.5	18.5	51.6	12.4	26.6	8.9	15.4	17.2	14.9	14.5	8.0	8.2	12.0	109.4	10.2	28.4	9.6	28.7	14.6	15.6	22.2	30.7	25.4	17.9	19.6	11.1	15.0	13.7	4.9
KIF3C		ENSG00000084731	"Kinesin family member 3C"	O14782	2	25926596-25982749	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 72.9"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035755			Approved	"Nuclear membrane,Nuclear bodies,Intermediate filaments"				"Nuclear bodies, Intermediate filaments"	"Nuclear membrane"	"HPA035755: AB_10602242"	"unprognostic (3.95e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.53e-2)"	"prognostic favourable (1.22e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	3.0	7.3	22.8	2.9	21.2	2.2	2.6	22.7	72.9	3.6	2.4	3.8	0.0	2.1	3.9	2.6	3.0	3.3	4.1	3.0	21.6	18.9	2.0	1.6	2.6	2.0	17.5	20.3	7.3	2.3	4.5	4.8	2.8	22.8	3.3	2.6	1.9	1.9	4.6	2.4	2.3	2.7	4.8	6.2	2.2	2.0	3.0	5.2	0.5	2.5	0.0	2.0	3.5	1.5	0.1	0.3	2.4	0.2	0.7	2.0	1.3	13.0	19.8	10.6	8.1	6.2	7.2	8.5	6.8	3.4	4.1	4.7	3.5	2.0	0.0	5.7	6.2	1.4	8.0	4.1	2.8	2.2	3.8	4.7	1.5	7.1	3.7	1.2	4.1	5.2	1.2	12.9	2.6	13.6	1.7	1.7	4.3	0.9	3.3	1.6	10.8	5.8	5.3	5.2	0.8	9.4	3.2	12.9	29.1	2.7	1.2	14.3	0.4	1.6	10.7	7.2	7.4	3.2	6.6	0.4	2.3	1.5	16.3	6.4	6.1	0.0	0.2	0.0	0.4	0.0	1.1	0.0	1.6	1.5	0.3	0.1	0.5	0.6	2.4	0.7	0.0	0.2	2.0	1.3	22.8	21.2	22.7	40.0	21.6	18.9	17.5	20.3	22.8	5.2
KLHDC2	"HCLP-1, LCP"	ENSG00000165516	"Kelch domain containing 2"	Q9Y2U9	14	49767608-49786385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000628	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nuclear bodies"				"Nucleoplasm, Nuclear membrane"	"Nuclear bodies"	"HPA000628: "	"unprognostic (2.65e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.52e-3)"	"unprognostic (4.54e-2)"	"unprognostic (9.72e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-3)"	"unprognostic (6.77e-3)"	"prognostic favourable (2.75e-10)"	"unprognostic (2.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.34e-2)"	17.0	20.2	18.2	9.6	18.0	7.6	20.7	21.0	22.3	15.4	22.0	10.8	16.2	15.9	18.4	14.3	13.6	13.4	15.2	47.1	16.0	14.3	29.7	41.7	12.6	13.1	17.6	16.8	22.9	43.2	16.2	15.5	11.1	17.6	16.9	16.1	18.5	16.2	18.8	40.7	14.9	22.5	20.7	13.5	10.2	20.3	21.7	18.3	15.0	24.8	13.1	9.5	23.9	13.0	13.1	7.0	15.0	7.0	12.5	19.9	8.7	8.4	7.1	13.4	6.5	19.3	16.9	14.1	8.9	16.9	11.2	11.4	4.1	11.5	16.9	12.5	15.8	7.6	8.1	8.1	9.6	11.6	9.2	5.2	5.3	9.7	14.1	11.1	4.6	17.4	14.0	5.1	10.2	10.2	6.7	12.6	8.9	9.9	11.4	4.8	9.8	20.9	9.1	14.3	10.2	5.1	18.0	16.6	13.2	14.9	27.6	9.6	10.5	4.3	8.7	10.4	8.2	8.2	4.6	17.4	11.2	9.9	5.8	5.8	5.4	8.8	7.0	15.0	9.2	4.5	11.5	13.0	14.0	14.5	7.0	13.1	19.9	13.3	6.8	12.5	4.4	5.4	13.3	8.7	18.2	18.0	21.0	22.3	16.0	14.3	17.6	16.8	17.6	18.3
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6;esophagus: 48.9"	"Group enriched"	"Detected in some"	14	"A-431: 68.4;CAPAN-2: 163.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 175.6"	"Group enriched"	"Detected in many"	8	"midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"		6800000	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavourable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavourable (1.27e-4)"	0.9	0.9	9.7	0.9	23.5	0.9	6.5	3.3	42.2	10.0	1.0	82.0	0.0	1.1	2.0	1.2	48.9	24.6	3.8	0.9	20.1	11.8	9.0	0.9	0.9	0.9	46.1	14.9	0.9	0.9	0.9	0.2	0.9	44.3	1.0	0.9	0.0	5.9	2.8	0.9	2.9	0.9	1.0	97.6	5.1	1.0	1.5	32.6	0.0	0.9	15.7	28.1	0.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.1	163.7	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.1	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	23.5	3.3	23.1	20.1	11.8	46.1	14.9	44.3	32.6
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 28.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"			5500000	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: "	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavourable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavourable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	38.0	42.1	31.9	46.1	30.7	22.1	33.3	32.9	33.5	37.6	37.9	29.7	39.9	24.5	39.3	35.4	51.2	33.1	35.0	43.5	28.1	30.5	33.8	48.8	35.8	50.5	31.6	35.3	47.2	32.3	42.3	29.4	34.6	34.9	36.1	39.3	23.7	35.2	45.9	74.6	31.7	32.1	40.7	36.6	50.3	35.7	62.4	34.8	47.6	37.0	34.3	62.8	50.8	47.5	5.4	4.0	28.2	3.9	3.7	6.3	2.8	43.2	73.6	46.9	42.6	22.7	39.5	47.1	51.5	46.2	67.6	53.1	128.4	25.7	55.7	35.2	48.0	30.6	84.6	47.5	102.7	34.2	51.6	61.6	59.4	40.2	23.4	69.6	40.6	32.0	21.0	77.6	76.0	44.5	69.6	38.2	52.2	47.0	64.6	20.9	44.6	46.6	40.0	82.9	32.4	27.7	61.9	41.2	38.3	35.2	18.9	29.8	41.0	26.9	37.0	73.9	45.9	38.4	62.4	46.7	54.0	79.9	31.5	33.7	54.1	4.3	3.5	7.1	4.9	3.6	6.3	5.4	5.5	5.5	2.1	5.1	5.2	4.9	28.2	3.7	3.9	4.0	4.0	2.8	31.9	30.7	32.9	33.3	28.1	30.5	31.6	35.3	34.9	34.8
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821410-52834295	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 11.3;skin 1: 34.3"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 97.6"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 0.2;hippocampal formation: 0.3;olfactory region: 0.5"	HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"			950000000	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA059347: "	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	4.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	34.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	11.3	0.1	0.1	0.2	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	97.6	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRTAP25-1	KAP25.1	ENSG00000232263	"Keratin associated protein 25-1"	Q3LHN0	21	30289145-30289514	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031438	Uncertain		Approved	"Nuclear membrane,Plasma membrane,Cytosol"				"Nuclear membrane"	"Plasma membrane, Cytosol"	"HPA031438: AB_10610000"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.0;kidney: 5.7;seminal vesicle: 7.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.2;HMC-1: 2.6;WM-115: 11.4"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 8.1"					"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Region enhanced"	"Detected in many"		"cerebellum: 21.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 20.4"	"HPA044307, HPA073521, HPA074382"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus"				Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: , HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavourable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	15.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1		5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.9	0.0	1.5	0.0	0.0	0.0	0.1	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1										
LRR1	"LRR-1, MGC20689, PPIL5"	ENSG00000165501	"Leucine rich repeat protein 1"	Q96L50	14	49598697-49614672	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 43.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA065703, HPA069364"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065703: , HPA069364: "	"unprognostic (2.73e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (7.34e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (4.90e-7)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.04e-2)"	5.7	6.0	1.7	7.8	2.5	14.2	5.0	2.4	2.8	3.2	8.5	2.5	2.6	7.8	4.2	2.8	7.2	3.7	4.6	6.9	1.5	1.1	4.3	5.6	4.5	9.6	2.5	1.6	3.1	6.5	1.3	1.6	4.8	2.3	3.3	6.2	4.3	6.0	5.5	7.5	4.8	7.9	3.5	3.3	8.1	4.9	43.9	2.0	28.0	3.8	7.7	9.2	4.7	4.6	12.5	14.6	20.3	18.8	7.3	12.7	8.5	22.3	16.0	12.8	12.7	2.9	2.1	14.9	12.1	11.1	27.6	25.0	14.4	18.9	20.4	8.4	7.3	14.6	15.3	11.0	19.4	20.7	12.1	9.8	11.6	9.2	2.3	23.2	12.9	2.2	3.8	12.4	5.6	13.1	9.9	13.7	13.6	20.1	27.1	19.4	7.7	21.0	19.1	21.7	14.6	9.3	9.3	12.8	7.2	11.6	13.9	8.4	17.9	15.2	5.0	19.2	31.8	8.4	14.9	7.5	10.8	22.2	9.8	16.3	14.3	16.9	12.3	20.3	9.3	18.8	11.8	12.5	11.9	12.6	12.7	9.2	9.5	10.7	6.6	7.3	13.1	14.6	12.7	8.5	1.7	2.5	2.4	2.8	1.5	1.1	2.5	1.6	2.3	2.0
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: "	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	12.1	16.6	11.0	13.3	14.4	35.7	13.8	16.5	24.4	12.2	21.3	10.1	6.3	18.1	12.9	14.1	17.0	13.4	13.2	19.2	11.9	12.1	18.3	18.9	11.4	18.2	11.0	12.6	11.3	18.5	11.5	12.8	12.6	14.0	12.6	22.0	13.6	24.2	11.3	25.1	11.9	22.0	12.4	9.8	17.5	16.8	17.6	7.9	29.0	18.9	13.9	19.9	14.3	13.2	27.9	27.6	39.7	22.2	26.8	39.8	21.4	19.1	8.9	14.0	15.5	12.2	13.3	8.5	11.5	18.7	25.6	24.0	18.1	7.8	14.9	6.6	13.5	12.6	21.7	16.0	19.8	13.7	16.9	18.4	9.8	15.5	13.2	10.8	11.2	13.4	19.7	19.0	11.7	19.1	23.6	8.1	17.7	18.0	9.6	20.1	8.6	11.5	11.2	10.9	14.1	18.2	15.4	16.7	16.9	8.3	12.8	54.2	15.0	28.9	10.4	13.7	11.5	9.0	18.3	10.4	8.8	35.0	12.5	18.3	15.0	39.7	22.2	25.0	25.7	22.1	25.8	27.9	30.8	28.4	27.6	25.6	32.3	29.0	18.6	26.8	19.9	18.3	39.8	21.4	11.0	14.4	16.5	24.4	11.9	12.1	11.0	12.6	14.0	7.9
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235126-46286297	"Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: "	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favourable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	19.4	16.7	14.2	21.5	25.3	19.5	19.0	26.6	29.2	18.3	17.2	27.7	19.3	15.4	24.8	18.0	18.1	21.1	16.3	17.9	14.4	13.2	15.5	13.3	18.2	21.9	16.5	14.6	23.7	17.5	25.7	20.6	18.2	18.2	17.7	17.6	21.3	22.1	21.4	52.9	18.2	19.9	19.5	15.1	20.7	18.7	15.7	15.7	31.8	19.6	15.7	26.0	21.1	16.4	4.8	4.8	3.8	4.9	3.0	6.9	4.1	15.7	15.6	18.2	19.7	15.0	18.7	16.6	17.4	21.4	16.6	13.4	14.1	9.4	22.5	14.4	18.4	9.4	24.0	14.6	14.5	23.0	21.8	36.9	14.9	11.1	13.5	16.7	20.9	14.5	12.7	22.5	15.6	17.5	43.9	17.2	19.0	9.0	17.9	11.3	31.3	13.0	23.3	11.5	20.3	8.1	14.6	15.4	16.4	22.2	14.7	17.0	20.1	17.4	22.1	17.3	13.2	14.3	13.0	31.4	34.7	14.0	15.6	16.2	22.4	1.5	4.7	3.8	6.1	4.9	6.5	2.9	3.7	6.9	4.8	4.8	3.3	3.4	2.9	3.0	2.7	4.2	4.4	4.1	14.2	25.3	26.6	29.2	14.4	13.2	16.5	14.6	18.2	15.7
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715115-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 52.2;PC-3: 40.4"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 549.1"	"Low region specificity"	"Detected in many"			HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: "	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	7.7	14.9	44.7	5.1	58.9	2.6	4.6	14.2	45.4	4.1	7.0	24.1	19.8	5.6	5.3	7.8	3.1	27.4	6.4	12.4	39.6	31.6	10.5	8.5	6.0	4.2	45.7	15.1	2.7	43.1	5.2	15.1	5.3	15.3	7.4	2.5	9.2	27.3	16.8	21.5	3.9	5.9	4.4	39.5	5.4	8.3	4.6	19.0	2.5	6.6	3.4	3.0	3.9	5.0	3.2	0.9	0.8	1.0	1.7	2.9	0.5	2.6	22.1	4.3	22.0	7.7	4.3	7.0	5.2	2.6	2.1	1.3	3.2	6.5	0.4	12.3	3.7	9.7	0.6	5.1	0.3	1.4	9.7	0.8	4.0	16.6	4.7	1.8	2.8	10.4	5.6	0.6	1.3	0.7	1.5	0.5	1.5	52.2	0.7	6.4	1.6	40.4	7.1	5.0	7.1	5.4	0.7	6.9	8.7	2.1	5.8	26.8	8.7	3.7	2.4	6.0	11.4	6.9	4.5	3.3	0.9	0.4	9.4	1.4	14.1	0.0	0.3	0.8	2.9	1.0	1.7	3.2	1.5	2.7	0.2	0.5	0.9	1.9	0.0	1.7	1.0	0.9	2.8	0.5	44.7	58.9	14.2	27.4	39.6	31.6	45.7	15.1	15.3	19.0
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453040-140479569	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	16.8	17.6	26.8	20.8	28.8	69.9	20.1	37.2	32.6	20.4	39.6	16.1	19.7	28.4	20.1	18.6	23.3	22.2	22.4	38.5	24.9	29.8	20.6	17.5	23.6	18.3	25.7	23.3	24.9	27.3	28.2	21.5	31.7	29.4	21.0	33.7	19.4	24.8	23.1	38.5	24.4	26.6	26.3	20.5	22.5	21.7	95.4	20.2	21.0	23.6	18.8	22.3	25.3	36.4	13.1	7.5	39.3	10.5	12.8	17.8	6.4	27.9	21.6	16.9	25.0	26.8	23.5	23.9	19.3	25.1	15.2	17.6	8.8	29.5	20.3	30.3	18.8	13.6	19.0	21.2	19.3	40.2	16.5	21.1	13.0	16.3	21.6	18.0	32.7	23.4	32.0	17.1	16.2	15.1	16.6	25.7	14.6	24.1	21.1	32.4	43.4	16.0	15.3	14.5	31.1	24.4	32.4	23.4	24.2	24.2	32.8	34.5	16.1	15.7	21.4	10.7	8.5	26.1	17.6	61.3	44.9	17.8	30.6	28.4	22.0	19.4	9.2	39.3	6.7	8.7	8.0	13.1	13.0	10.1	7.5	10.9	17.8	11.3	18.1	12.8	10.5	2.5	14.0	6.4	26.8	28.8	37.2	32.6	24.9	29.8	25.7	23.3	29.4	20.2
MLX	"bHLHd13, MAD7, MXD7, TCFL4"	ENSG00000108788	"MLX, MAX dimerization protein"	Q9UH92	17	42567068-42573239	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025329, HPA052766, HPA064438"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB025329: , HPA052766: , HPA064438: "	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.55e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.25e-1)"	21.3	19.2	10.4	12.6	11.9	8.3	22.5	10.3	14.3	12.3	32.2	10.8	15.4	27.5	11.0	15.1	18.8	10.5	19.2	38.1	9.8	9.8	23.5	34.7	19.0	18.6	11.3	6.6	10.4	36.8	8.5	13.0	13.7	9.4	13.4	23.1	11.6	18.5	14.8	43.3	15.6	42.5	12.1	10.2	18.7	20.6	7.4	8.9	20.3	23.5	24.9	19.7	16.5	13.1	14.6	26.3	34.7	33.5	12.8	18.2	23.0	16.0	18.6	14.6	14.8	22.3	25.8	10.1	24.2	21.5	26.1	23.7	16.8	16.7	19.4	17.0	20.5	24.3	26.6	15.6	23.0	15.3	25.0	20.0	13.4	18.6	26.3	26.8	28.9	22.3	17.5	20.9	19.2	19.2	21.8	17.4	29.7	21.4	37.6	13.2	10.3	16.9	17.0	30.4	20.7	21.1	19.9	22.8	11.3	10.7	13.9	27.1	28.6	31.8	13.6	23.3	15.1	25.4	35.6	17.7	20.0	18.2	26.0	17.2	27.3	14.2	25.0	34.7	14.3	30.8	15.8	14.6	14.8	14.3	26.3	11.8	13.1	13.1	32.3	12.8	33.5	14.1	18.2	23.0	10.4	11.9	10.3	14.3	9.8	9.8	11.3	6.6	9.4	8.9
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251539-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"				"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavourable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	17.2	16.5	20.4	16.9	18.5	12.0	21.6	10.7	21.7	12.1	13.8	12.4	10.2	17.5	15.6	15.2	21.6	18.8	11.8	11.7	19.1	15.9	13.6	23.7	10.5	23.0	16.1	19.1	18.7	41.2	10.2	8.8	12.5	15.1	12.2	17.6	10.6	13.2	11.9	22.8	15.3	19.3	17.3	10.0	14.5	13.7	21.6	11.6	14.5	12.9	29.3	22.7	11.4	12.4	14.7	12.8	1.0	8.2	10.6	15.7	7.2	24.1	17.2	14.2	18.6	6.9	11.1	12.6	18.9	10.7	32.5	21.4	24.8	25.1	35.7	15.9	15.6	19.2	39.4	28.5	32.8	12.7	30.1	26.4	15.4	21.2	8.8	34.8	11.1	9.7	18.9	36.6	19.0	18.2	39.9	11.6	19.2	17.7	28.3	25.2	18.2	26.2	26.6	17.4	27.6	17.6	8.3	23.0	16.8	14.5	20.0	20.0	14.2	20.5	11.9	17.8	22.0	27.2	32.2	9.4	16.4	47.1	17.3	44.8	28.3	0.7	7.5	0.7	7.9	8.2	15.7	14.7	9.6	10.8	11.4	13.1	13.0	11.6	1.0	10.6	6.2	12.8	6.7	7.2	20.4	18.5	10.7	21.7	19.1	15.9	16.1	19.1	15.1	11.6
NBAS	NAG	ENSG00000151779	"Neuroblastoma amplified sequence"	A2RRP1	2	15166909-15561330	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036817	Approved		Approved	"Nuclear membrane,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nuclear membrane, Nucleoli"	"HPA036817: AB_10670925"	"unprognostic (1.72e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (5.84e-5)"	16.8	18.1	23.2	16.3	30.9	21.9	22.5	21.5	28.3	21.9	17.1	20.6	17.4	13.3	27.1	23.4	14.1	18.7	13.5	21.6	20.9	21.5	19.1	16.9	15.4	16.3	19.3	20.8	24.1	28.6	34.1	35.5	16.2	24.9	16.9	17.7	16.8	22.9	19.0	26.5	23.4	20.5	21.0	18.1	18.1	19.0	31.4	16.7	23.8	20.1	14.6	20.0	14.4	15.2	5.3	6.0	3.2	8.7	9.4	9.9	3.6	5.4	7.2	8.0	5.5	20.9	23.0	8.2	10.1	11.1	7.9	8.0	7.2	7.9	7.0	2.3	15.3	6.6	8.6	12.7	9.4	6.9	5.5	26.6	6.4	20.1	21.5	6.9	13.6	15.1	10.1	10.4	17.5	16.2	20.6	8.0	12.0	6.7	5.7	15.5	6.9	6.9	6.0	14.0	8.3	16.3	7.4	4.7	7.7	8.6	7.1	12.7	5.0	6.3	14.0	10.0	6.2	7.1	7.3	12.0	10.2	9.9	17.8	8.1	8.9	1.4	5.7	3.2	7.6	3.9	9.5	5.3	5.9	9.9	5.2	5.1	5.9	6.1	1.0	9.4	8.7	6.0	6.9	3.6	23.2	30.9	21.5	28.3	20.9	21.5	19.3	20.8	24.9	16.7
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765460-53838860	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"				"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: , HPA070882: "	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favourable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavourable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	8.8	6.7	3.3	8.6	5.7	4.9	12.9	10.9	7.7	4.8	8.4	5.1	1.9	6.2	6.0	5.4	11.0	5.3	2.9	5.5	4.3	2.8	4.9	11.7	4.4	10.6	8.0	1.5	4.6	6.0	7.6	5.5	5.5	6.6	4.0	10.7	5.5	6.4	3.7	7.1	6.8	6.5	5.0	7.5	7.1	5.8	17.4	7.5	9.1	5.8	6.7	13.0	6.4	5.8	5.5	3.8	2.0	7.2	4.0	8.2	3.4	19.6	10.4	14.2	14.5	5.2	5.3	16.7	13.5	10.1	21.2	17.2	15.3	13.2	38.9	8.9	6.0	23.8	23.9	14.1	30.1	9.7	17.2	18.9	15.3	13.0	4.9	30.4	10.8	3.2	5.6	20.9	12.5	12.8	21.6	5.6	11.6	7.1	14.8	12.1	33.6	16.6	16.8	22.9	21.3	9.9	13.6	8.6	10.9	12.1	23.6	11.6	18.3	16.1	7.4	11.1	11.1	15.2	24.2	6.2	15.3	27.7	9.2	23.1	13.8	0.0	3.2	2.0	4.5	7.2	6.9	5.5	4.3	4.0	3.8	4.1	8.2	6.3	0.2	4.0	4.5	3.3	4.7	3.4	3.3	5.7	10.9	7.7	4.3	2.8	8.0	1.5	6.6	7.5
NR4A1	"GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3"	ENSG00000123358	"Nuclear receptor subfamily 4 group A member 1"	P22736	12	52022832-52059507	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 25.3;MCF7: 28.8;SK-BR-3: 27.3;SK-MEL-30: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 18.2;non-classical monocyte: 24.4"	"Lineage enriched"	"Detected in many"	13	"monocytes: 24.4"	"Group enriched"	"Detected in many"	5	"amygdala: 35.3;basal ganglia: 43.1;cerebral cortex: 77.4;hippocampal formation: 65.3;olfactory region: 79.3"	"Low region specificity"	"Detected in all"			"HPA059742, HPA070142"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA059742: AB_2684119, HPA070142: "	"unprognostic (2.40e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (6.99e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-2)"	"unprognostic (8.89e-3)"	69.1	111.3	4.0	58.1	12.9	5.7	25.0	5.4	10.9	32.3	23.3	21.1	46.0	5.6	49.8	33.9	28.1	63.3	99.9	76.7	4.8	5.0	17.9	12.1	50.1	8.3	7.5	5.9	177.3	16.1	28.9	51.8	7.6	13.1	88.3	13.8	43.7	66.8	203.2	32.3	23.4	24.3	98.4	6.8	5.1	32.8	11.8	6.4	11.9	34.7	35.8	14.9	71.4	54.5	0.4	1.8	0.2	24.4	0.1	0.2	0.7	1.8	9.5	1.8	3.4	1.3	0.4	7.2	1.8	3.6	1.4	2.0	9.3	1.8	2.0	0.8	3.2	1.0	5.6	0.8	0.8	0.1	2.0	2.6	25.3	2.6	1.4	1.0	8.9	0.3	1.1	1.4	0.1	0.4	2.5	0.4	0.1	28.8	0.7	2.7	5.2	1.0	0.8	0.3	4.7	0.0	0.7	1.5	4.7	5.9	27.3	47.6	1.7	3.0	0.0	1.4	4.6	0.9	1.5	16.1	7.6	4.1	0.9	0.7	7.9	0.1	0.6	0.0	0.1	18.2	0.1	0.4	0.0	0.0	1.8	0.4	0.2	0.0	0.2	0.1	24.4	0.1	0.1	0.7	4.0	12.9	5.4	10.9	4.8	5.0	7.5	5.9	13.1	6.4
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686734-68745809	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"				Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: "	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavourable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	18.3	12.6	10.2	16.5	13.2	18.7	17.4	20.7	15.2	19.0	12.2	12.1	12.2	9.2	18.6	18.0	14.0	16.6	8.5	12.1	12.2	6.6	12.1	11.1	12.5	21.4	13.2	10.2	19.8	12.5	14.2	16.2	23.5	12.2	12.6	15.3	11.3	13.0	11.8	13.9	14.8	15.8	13.7	12.5	19.7	12.0	20.5	15.9	40.6	12.5	13.1	22.5	17.8	13.1	13.6	7.0	9.5	14.2	20.6	17.0	8.0	17.0	22.0	26.3	19.0	7.8	10.0	28.5	18.7	10.8	28.2	23.6	22.1	14.5	31.3	18.3	8.9	19.7	29.5	13.8	37.6	29.3	21.9	35.7	15.8	18.5	4.9	31.4	12.1	5.2	6.6	22.5	14.8	16.8	42.5	22.6	17.6	20.7	25.8	27.5	28.9	21.6	26.5	31.6	18.8	12.2	18.2	15.5	15.9	20.7	15.6	11.2	23.4	15.2	10.2	15.4	15.7	17.8	22.7	9.9	19.7	37.9	11.8	23.0	18.1	6.3	6.5	9.5	13.1	8.5	17.0	13.5	13.0	14.0	7.0	13.6	16.2	14.5	1.7	20.6	14.2	5.5	13.4	8.0	10.2	13.2	20.7	15.2	12.2	6.6	13.2	10.2	12.2	15.9
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"				"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favourable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	8.8	10.9	9.1	13.7	21.4	4.1	15.3	18.9	12.6	9.2	8.6	5.6	5.8	7.3	9.6	9.0	11.7	10.6	9.1	7.9	11.1	6.8	11.9	16.4	9.5	9.3	11.5	5.1	13.1	17.2	8.9	13.1	9.0	8.8	9.3	10.7	7.3	9.7	9.6	9.1	10.9	7.1	10.5	7.6	7.8	9.3	25.8	9.7	19.1	10.3	12.6	12.7	8.0	10.2	8.9	3.8	1.7	6.8	5.9	10.5	5.0	9.9	10.7	16.8	9.9	6.1	5.9	12.2	12.1	9.8	18.3	17.5	19.7	12.2	17.1	11.3	6.3	8.7	23.0	13.4	29.6	15.2	15.3	16.0	9.0	21.0	4.6	11.6	10.9	4.3	7.1	15.5	14.9	10.7	14.4	12.6	13.9	11.6	13.4	13.8	28.5	33.3	16.4	13.2	12.1	16.8	12.3	14.8	10.4	11.2	13.1	12.7	8.5	8.1	5.6	14.4	10.2	11.6	13.4	8.5	18.4	18.1	9.8	8.5	19.3	0.0	4.8	1.7	6.1	6.3	10.5	8.9	7.8	7.5	3.8	7.9	9.6	8.4	0.1	5.9	6.8	3.6	7.7	5.0	9.1	21.4	18.9	12.6	11.1	6.8	11.5	5.1	8.8	9.7
PAPD7	"LAK-1, POLK, POLS, TRF4, TRF4-1"	ENSG00000112941	"Poly(A) RNA polymerase D7, non-canonical"	Q5XG87	5	6713007-6757048	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045487, HPA046742"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"				Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA045487: AB_2679346, HPA046742: AB_2679781"	"unprognostic (1.45e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.62e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (7.99e-5)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.60e-2)"	"prognostic favourable (8.55e-4)"	13.5	7.9	9.6	13.9	11.1	25.8	16.3	22.7	12.3	15.1	16.6	10.6	14.8	9.5	13.2	8.0	12.2	11.3	11.4	8.6	10.7	7.3	9.7	19.9	13.2	14.1	14.8	5.8	18.5	13.3	13.2	12.2	10.0	9.0	11.6	8.3	10.2	17.0	10.6	10.4	16.7	13.1	13.9	7.9	14.8	10.1	11.1	11.7	25.4	11.3	11.3	11.6	12.5	34.9	1.9	3.8	0.7	0.7	0.5	2.3	0.8	16.3	11.1	13.7	16.8	9.9	8.9	19.7	11.1	14.0	13.9	15.8	11.5	9.1	12.0	8.6	13.7	12.2	11.1	8.6	12.8	13.4	7.1	6.1	35.1	6.2	6.2	9.2	9.3	6.0	7.5	15.5	10.0	8.1	8.2	15.9	11.3	9.0	12.5	12.0	7.4	8.7	11.3	11.6	3.0	5.5	9.4	13.6	10.4	26.6	12.9	7.6	7.8	5.1	7.1	16.7	17.5	14.6	15.5	15.2	6.3	10.6	10.8	8.6	10.3	0.0	0.7	0.7	2.1	0.4	2.3	1.9	1.7	1.6	1.2	1.5	1.9	1.7	0.4	0.5	0.6	3.8	1.8	0.8	9.6	11.1	22.7	12.3	10.7	7.3	14.8	5.8	9.0	11.7
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18029944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Enhanced	"Nuclear membrane,Centrosome,Cytosol"				Centrosome	"Nuclear membrane, Cytosol"	"CAB058695: , HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	19.6	19.0	26.2	26.7	40.4	25.1	25.1	29.2	29.0	25.0	21.1	21.6	22.8	12.4	23.3	27.3	16.4	26.4	17.8	23.0	22.9	18.4	18.8	22.0	19.1	21.1	24.5	24.9	29.1	27.0	42.0	35.8	19.8	26.4	20.2	16.3	16.2	19.4	25.3	63.1	17.6	18.3	26.7	27.2	20.8	17.9	80.0	28.0	40.2	28.2	19.1	20.4	27.0	22.6	11.5	14.9	19.9	7.5	11.2	13.0	4.3	20.3	21.7	33.4	44.2	18.9	19.7	17.3	17.2	21.2	18.4	20.8	14.7	12.2	26.7	11.9	17.1	14.8	21.3	15.8	31.4	8.8	8.2	45.8	15.4	29.8	21.1	20.0	11.8	17.1	16.9	21.3	23.7	21.1	30.9	20.8	22.4	10.2	42.9	33.2	27.5	6.3	25.9	29.9	9.5	15.2	28.3	25.6	19.3	18.4	10.1	26.4	15.9	29.3	18.8	16.8	13.7	20.5	14.5	8.9	19.6	23.9	14.2	22.1	17.1	19.9	6.0	14.4	11.5	3.8	12.0	11.1	10.4	13.0	5.9	11.5	11.6	11.6	6.4	11.2	7.5	14.9	10.3	4.3	26.2	40.4	29.2	29.0	22.9	18.4	24.5	24.9	26.4	28.0
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950381	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	19.1	11.6	14.0	16.8	19.0	14.1	17.2	25.1	19.2	15.9	15.9	16.1	8.1	8.1	19.1	11.6	16.5	14.2	14.8	15.2	14.1	13.8	11.2	11.1	16.5	17.3	14.9	13.0	18.9	9.4	17.9	20.0	15.6	15.0	14.7	11.7	14.7	15.3	15.7	46.6	12.9	12.3	17.2	18.9	20.8	12.7	17.4	15.2	19.4	14.2	14.5	20.8	18.7	21.8	12.0	8.2	23.6	11.9	13.0	12.4	6.5	9.6	7.7	13.5	19.9	9.8	11.3	12.6	11.0	10.5	11.1	9.7	22.4	7.3	16.1	10.0	14.6	6.0	12.4	15.3	13.6	7.2	5.3	30.0	14.7	8.3	9.9	14.3	11.7	8.8	21.6	11.7	18.1	12.1	12.2	10.4	12.7	5.7	14.5	8.4	6.7	9.6	10.6	20.0	9.5	8.8	6.7	12.3	10.0	19.6	22.8	10.1	18.0	10.7	16.9	24.6	5.6	12.7	11.2	9.6	11.4	11.8	18.2	10.5	12.6	11.9	8.6	23.6	10.6	9.0	11.3	12.0	10.5	11.9	8.2	9.8	12.0	12.4	20.5	13.0	11.9	7.7	5.5	6.5	14.0	19.0	25.1	19.0	14.1	13.8	14.9	13.0	15.0	15.2
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009914, HPA038139, HPA038140"	Enhanced		Approved	"Nuclear membrane,Plasma membrane,Cytosol"				Cytosol	"Nuclear membrane, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.5	2.1	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.5	1.9	0.2	1.2	0.6	3.0	0.1	1.9	0.5	2.7	1.0	1.1	2.2	1.8	0.4	1.2	0.7	3.4	0.9	0.8	0.5	4.3	3.0	2.3	21.1	1.0	0.8	0.3	2.5	0.5	6.0	1.5	1.2	0.7	0.7	0.5	0.8	0.9	4.6	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686236-4701590	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 108.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"	"Intracellular and membrane"		2200000	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: "	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.96e-4)"	"prognostic unfavourable (4.64e-4)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	24.6	27.3	63.4	14.2	73.1	19.8	30.5	87.5	116.1	42.0	43.4	61.6	8.5	10.6	36.3	17.7	23.0	24.1	31.4	54.1	64.6	48.9	38.5	22.2	22.2	14.7	47.2	65.6	49.6	11.8	20.7	24.9	18.7	71.6	43.8	20.9	34.1	17.1	45.0	21.8	26.7	13.5	40.8	53.1	20.3	18.1	19.1	51.4	2.9	25.6	11.8	16.4	27.0	22.3	4.6	10.5	108.1	11.7	3.6	16.7	10.0	24.2	20.0	4.6	7.1	37.3	22.8	4.1	40.2	57.9	19.5	19.9	6.6	18.8	4.4	9.3	78.3	56.5	5.0	54.7	36.6	3.6	4.3	0.0	2.3	20.6	45.9	7.9	1.8	20.6	78.9	83.4	65.2	16.7	2.3	15.8	22.4	5.4	3.1	4.8	3.7	29.8	3.8	12.2	4.0	9.8	4.3	5.4	0.8	11.4	16.0	57.1	3.3	4.1	25.1	31.8	14.6	17.7	32.6	7.3	14.7	14.8	25.6	5.8	114.4	108.1	11.7	0.8	11.9	9.7	16.7	4.2	9.8	9.4	10.5	4.6	5.8	6.8	0.7	3.6	7.6	3.7	11.4	10.0	63.4	73.1	87.5	90.4	64.6	48.9	47.2	65.6	71.6	51.4
QRICH2	DKFZP434P0316	ENSG00000129646	"Glutamine rich 2"	Q9H0J4	17	76274049-76307998	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 27.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA052219	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA052219: "	"unprognostic (3.11e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.82e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-3)"	0.9	0.8	1.2	0.9	2.2	1.9	0.9	5.7	2.0	0.9	0.9	0.9	0.9	0.3	0.9	1.0	1.0	1.2	0.9	0.9	1.4	2.0	0.9	1.1	1.1	0.9	1.4	0.9	0.9	1.3	0.6	0.9	1.4	0.9	0.9	0.8	0.9	5.6	0.9	1.4	1.7	0.9	0.9	1.2	0.9	0.3	27.4	0.9	0.9	3.0	0.9	0.9	0.9	0.9	0.9	0.0	0.0	0.1	0.3	0.4	0.3	1.1	2.5	4.7	5.3	2.6	2.3	2.2	2.2	0.5	1.7	0.5	1.3	0.5	6.5	0.9	1.3	0.5	6.2	1.1	2.0	1.8	3.8	0.5	1.7	5.7	1.3	0.8	2.9	2.1	1.0	1.9	0.1	2.0	3.4	1.2	0.5	3.7	3.4	0.7	1.9	5.1	7.5	3.9	0.2	0.8	2.3	4.3	4.3	1.1	0.6	2.6	1.9	2.7	2.1	1.4	5.0	6.7	2.6	1.7	1.6	0.6	1.5	3.8	1.6	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.2	2.2	5.7	2.0	1.4	2.0	1.4	0.9	0.9	0.9
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538116	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	Transport	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	10	"neutrophil: 55.1"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"				Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: "	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	19.7	14.6	23.2	14.8	24.3	17.9	19.1	27.1	27.2	17.1	20.7	14.0	54.7	12.5	15.9	16.7	33.7	17.5	13.7	21.4	24.7	19.6	30.6	14.2	15.1	14.6	23.1	13.7	18.8	10.4	19.8	15.3	28.8	19.6	24.3	17.4	9.8	17.6	44.8	24.3	47.5	13.4	22.7	20.6	19.3	17.4	8.5	23.1	15.4	15.7	23.4	16.4	24.3	26.3	2.5	5.5	55.1	4.5	4.3	3.2	1.2	22.7	15.4	13.7	15.5	15.8	24.9	18.1	27.6	15.0	14.2	15.3	17.0	22.6	29.0	20.2	25.2	13.1	18.9	20.7	17.8	28.8	18.3	15.4	14.2	12.7	12.9	45.0	17.8	17.3	20.8	19.8	19.8	23.9	21.9	26.8	22.3	18.0	27.0	19.8	10.6	15.7	36.4	24.5	21.3	19.6	31.7	18.5	15.1	23.9	20.9	12.2	12.9	20.9	28.5	42.1	32.4	29.1	32.7	16.6	16.5	31.4	18.3	21.4	15.9	3.1	2.8	4.3	3.2	2.9	2.7	2.5	2.7	2.6	2.4	2.4	2.3	2.9	55.1	4.3	4.5	5.5	1.7	1.2	23.2	24.3	27.1	27.2	24.7	19.6	23.1	13.7	19.6	23.1
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nuclear membrane,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	1.6	4.9	1.3	1.8	2.1	0.8	1.8	10.4	3.6	1.8	2.0	2.9	1.1	1.5	5.3	2.8	1.0	2.2	2.7	1.5	1.4	2.2	2.4	1.8	4.1	2.4	1.5	1.7	1.8	7.2	3.6	9.4	5.0	5.3	2.4	2.3	5.4	5.1	2.7	1.0	1.1	2.6	2.4	3.1	1.0	2.5	16.3	0.4	0.1	4.7	0.1	1.4	1.5	1.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.1	5.4	4.5	1.5	0.5	3.4	3.9	1.8	2.8	1.7	2.3	0.0	0.1	3.3	3.8	0.0	0.0	1.7	5.7	0.0	4.3	1.1	2.1	0.0	1.5	0.0	0.0	4.4	0.3	0.3	0.0	2.6	0.4	0.0	1.6	2.7	0.0	0.0	0.4	0.5	0.0	3.5	0.0	0.9	1.4	0.3	2.0	0.0	5.4	2.8	0.9	1.5	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	2.1	10.4	3.6	1.4	2.2	1.5	1.7	5.3	0.4
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41245611-41286251	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"				"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favourable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	12.2	30.7	23.5	16.9	28.4	28.5	16.1	17.6	41.1	8.5	11.8	23.1	7.3	12.7	9.5	9.4	26.1	11.5	13.7	11.5	26.9	30.4	12.0	25.1	11.5	19.5	31.7	28.6	10.6	20.2	11.0	17.7	16.1	28.1	11.4	9.6	7.1	16.3	13.3	12.5	51.6	12.8	12.3	22.0	14.2	16.0	64.3	28.3	22.1	12.7	14.4	21.7	13.3	29.2	8.7	7.6	8.2	14.8	7.1	13.1	9.7	58.7	30.9	20.1	21.0	10.9	9.0	24.5	51.0	27.9	51.4	27.0	37.5	19.4	31.7	41.1	37.3	54.7	36.6	40.1	31.1	25.6	56.8	26.8	30.1	29.2	13.6	43.3	20.2	8.7	19.1	36.6	32.5	26.9	34.4	22.6	29.2	50.4	25.2	35.2	22.0	36.8	31.0	19.9	33.4	20.1	33.7	18.3	12.2	36.2	32.1	18.6	18.9	17.5	41.6	39.4	37.8	21.7	41.8	16.8	22.4	30.2	27.5	30.8	22.7	2.8	9.5	8.2	11.2	11.2	13.1	7.9	11.3	10.3	7.1	8.7	10.5	8.0	2.7	7.1	14.8	7.6	11.6	9.7	23.5	28.4	17.6	41.1	26.9	30.4	31.7	28.6	28.1	28.3
RETREG3	"DKFZp686B1036, FAM134C, FLJ33806"	ENSG00000141699	"Reticulophagy regulator family member 3"	Q86VR2	17	42579513-42610623	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016492	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA016492: AB_1853027"	"unprognostic (6.79e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.78e-1)"	"prognostic favourable (1.61e-4)"	"unprognostic (5.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (6.82e-4)"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.43e-2)"	23.2	17.4	11.9	15.8	15.6	5.8	16.3	23.1	21.9	17.0	18.8	13.2	15.5	13.1	25.4	20.9	21.6	15.0	20.8	10.0	11.2	12.3	16.0	28.7	16.2	19.0	11.3	9.8	17.4	43.2	19.6	16.5	29.4	13.7	19.4	16.1	32.5	24.6	14.1	18.5	31.1	17.5	15.7	7.8	24.0	17.1	27.2	8.5	29.9	17.8	16.7	26.3	14.8	17.1	14.1	7.8	22.6	11.4	13.7	27.8	16.6	6.4	20.2	8.9	14.4	22.9	12.7	12.7	9.3	12.7	11.1	13.1	9.5	14.1	14.3	13.1	15.1	25.5	11.4	14.0	10.8	15.3	10.9	5.8	12.3	16.9	15.7	9.9	15.0	19.4	19.2	12.1	12.4	11.9	11.8	14.3	8.7	11.2	14.5	14.5	5.6	5.0	7.9	13.8	14.6	12.7	21.0	16.0	11.0	10.0	8.2	14.1	23.2	7.8	14.9	12.1	7.4	11.9	8.8	24.6	29.2	12.7	11.0	6.4	9.1	22.6	8.0	17.7	24.2	10.0	21.2	13.0	20.0	23.0	7.8	14.1	19.8	22.2	7.2	13.7	11.4	7.7	27.8	16.6	11.9	15.6	23.1	21.9	11.2	12.3	11.3	9.8	13.7	8.5
REXO5	NEF-sp	ENSG00000005189	"RNA exonuclease 5"	Q96IC2	16	20806429-20849668	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"blood: 33.9;testis: 119.4"	"Cell line enhanced"	"Detected in many"		"K-562: 24.1;U-266/70: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	15	"basophil: 33.9"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 33.9"					"Low region specificity"	"Detected in all"			"HPA040755, HPA040868"	Enhanced		Approved	"Nuclear membrane,Nucleoli,Endoplasmic reticulum"				"Nuclear membrane"	"Nucleoli, Endoplasmic reticulum"	"HPA040755: AB_10965790, HPA040868: AB_10963549"	"unprognostic (2.39e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.42e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.93e-2)"	0.8	0.7	0.7	1.4	1.9	2.6	1.0	1.0	1.0	0.4	0.6	0.6	0.2	0.7	0.9	0.8	0.6	1.1	0.7	1.1	0.6	0.5	0.5	0.5	0.6	0.7	0.4	1.2	0.8	0.6	3.3	0.4	0.4	0.6	1.4	0.8	0.7	0.8	0.7	0.4	0.6	0.6	0.7	0.3	0.3	1.6	119.4	0.4	4.1	0.3	0.5	0.9	0.8	0.6	0.0	0.3	33.9	0.2	0.8	0.7	0.1	6.3	3.5	5.7	2.5	2.3	4.8	1.9	4.2	4.7	4.7	5.3	2.6	5.5	3.9	6.8	3.6	3.2	4.3	1.9	5.0	4.0	3.1	6.4	5.4	3.6	0.5	9.5	9.4	2.2	0.8	5.5	7.2	1.6	24.1	17.3	11.5	8.2	1.5	7.2	3.1	3.7	7.7	10.6	6.9	1.4	2.1	5.1	5.7	4.0	5.4	1.3	9.2	8.1	0.8	3.5	3.1	4.6	5.1	24.9	16.8	1.5	7.3	12.3	3.3	33.9	0.2	2.2	0.1	0.0	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.7	0.1	0.7	1.9	1.0	1.0	0.6	0.5	0.4	1.2	0.6	0.4
SAMD15	"C14orf174, FAM15A, FLJ35963"	ENSG00000100583	"Sterile alpha motif domain containing 15"	Q9P1V8	14	77376689-77391497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 29.1;testis: 22.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			"HPA030673, HPA030677"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"				"Nucleoplasm, Nuclear membrane, Nucleoli"		"HPA030673: AB_10600655, HPA030677: AB_10599938"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.83e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.76e-2)"	0.8	1.3	5.3	0.5	6.7	0.9	1.5	0.8	3.3	1.2	0.7	2.2	3.1	0.6	1.5	7.5	0.7	6.2	1.5	0.6	3.7	2.9	6.0	0.6	1.8	1.9	1.4	3.1	3.2	2.7	5.2	29.1	0.5	7.9	1.3	0.5	4.4	0.8	1.1	0.5	0.8	0.6	0.6	1.5	0.7	0.7	22.1	2.3	0.1	6.9	0.0	1.8	1.9	0.7	0.6	0.2	2.3	0.5	0.6	0.4	0.1	3.5	4.8	1.9	4.0	0.5	2.1	1.8	1.4	1.3	3.9	3.5	3.5	3.2	3.9	1.6	1.4	3.4	1.4	2.0	5.4	0.3	0.7	0.6	1.4	0.9	0.2	0.7	4.2	1.9	1.3	3.3	0.4	2.6	0.4	1.2	1.6	10.6	0.9	0.4	0.8	1.5	1.7	1.8	0.2	6.8	1.9	4.2	2.6	5.0	0.8	0.7	6.3	1.2	1.0	3.7	2.2	3.8	1.9	0.6	3.2	2.6	4.6	0.2	1.8	0.7	0.5	1.2	0.2	0.1	0.1	0.2	0.2	0.1	0.2	0.6	0.3	0.4	2.3	0.6	0.5	0.1	0.4	0.1	5.3	6.7	0.8	3.3	3.7	2.9	1.4	3.1	7.9	2.3
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582860	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 99.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 166.5"	"Group enriched"	"Detected in all"	5	"granulocytes: 166.5;monocytes: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"		1500000	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	106.2	32.0	28.5	37.6	45.2	51.5	67.4	20.9	29.0	42.7	28.4	18.8	22.2	19.7	38.4	28.2	37.8	28.0	47.9	36.9	32.1	25.8	41.4	41.7	73.1	49.7	33.4	16.9	35.5	20.1	36.4	16.4	68.5	47.6	35.5	33.6	53.0	41.5	20.7	22.5	24.7	34.3	37.9	39.0	70.1	31.0	25.4	22.2	34.3	44.4	23.4	21.4	50.0	44.2	5.9	21.7	166.5	44.8	3.4	9.8	29.7	14.4	22.4	23.9	12.4	89.4	77.1	10.5	14.9	53.2	21.6	28.5	8.9	30.3	0.0	24.0	19.9	6.0	12.9	17.1	26.8	2.6	11.0	21.7	19.9	7.1	99.4	5.5	35.4	52.6	23.2	21.7	65.3	51.8	10.7	12.7	49.0	3.8	12.2	6.5	14.9	6.4	5.9	7.3	2.8	34.4	15.2	10.4	18.9	15.9	6.8	73.0	6.2	15.2	44.5	20.9	9.0	24.6	9.5	3.8	5.1	8.7	53.2	0.0	18.7	52.9	44.8	43.7	5.7	30.0	7.1	5.9	7.6	6.0	21.7	5.4	9.8	7.4	166.5	3.4	26.4	6.0	8.5	29.7	28.5	45.2	20.9	29.0	32.1	25.8	33.4	16.9	47.6	22.2
SIPA1L2	KIAA1389	ENSG00000116991	"Signal induced proliferation associated 1 like 2"	Q9P2F8	1	232397965-232561558	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 33.4;NTERA-2: 26.7;WM-115: 22.6"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024181, HPA027224"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Golgi apparatus"				"Nuclear bodies"	"Nuclear membrane, Golgi apparatus"	"HPA024181: AB_1856886, HPA027224: "	"unprognostic (2.34e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.98e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.57e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (8.15e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.84e-3)"	"unprognostic (3.45e-3)"	4.1	1.1	3.6	2.9	3.3	2.1	3.4	0.3	7.6	3.2	8.9			1.6	1.9	1.0	8.7	1.2	4.4	16.2	3.1	3.9	1.6	2.4	6.5	0.8	6.5		6.7	1.4	3.9	3.2	10.0		2.9	10.5		3.3	2.3	2.5	3.3	3.3	3.7	3.0	4.5	2.0	3.4			3.4		1.1	4.7	5.7	0.0	1.2	4.3	1.2	2.0	2.4	0.2	0.0	3.6	33.4	0.2	0.2	0.0	14.5	0.6	1.2	1.5	1.1	1.4	0.0	2.8	6.7	12.6	0.8	6.8	1.0	1.4	0.0	6.3	0.0	3.2	0.0	3.1	0.4	3.6	1.9	4.7	0.3	3.0	7.7	0.0	0.0	0.7	1.5	3.5	0.3	26.7	5.4	0.0	0.0	1.7	4.2	5.2	1.8	5.8	11.1	0.3	4.5	0.7	0.4	2.7	4.0	0.0	8.6	1.3	3.1	0.0	0.0	4.9	3.0	22.6	0.0	0.6	0.0	0.2	1.2	2.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	4.3	2.0	0.9	1.2	0.0	0.2										
SMIM13	C6orf228	ENSG00000224531	"Small integral membrane protein 13"	P0DJ93	6	11094033-11138733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA065706	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus"				"Nucleoplasm, Nuclear membrane, Golgi apparatus"		"HPA065706: "	"unprognostic (6.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (1.04e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.45e-2)"	5.7	4.2	7.5	2.8	13.0	2.0	4.5	13.3	26.4	4.3	3.2	7.7	1.1	3.1	4.6	3.2	8.5	3.0	3.7	5.7	6.5	2.8	3.9	8.7	5.2	2.3	9.5	8.3	3.8	3.2	7.6	2.8	11.4	14.3	4.3	3.3	2.8	5.3	4.6	9.1	13.7	3.9	4.7	4.9	5.1	3.4	9.4	8.1	1.7	3.9	2.1	2.6	3.3	4.9	0.5	2.4	1.3	0.4	1.2	1.0	0.4	5.6	4.9	7.6	6.4	7.9	9.1	8.0	15.9	6.8	8.2	9.2	6.5	1.8	7.1	21.7	5.1	5.0	15.8	5.6	14.9	3.9	11.5	7.4	5.5	5.1	10.6	13.7	1.7	10.8	15.6	8.4	11.1	8.7	10.4	3.0	15.6	3.1	5.8	8.0	3.6	4.3	7.7	14.1	9.9	5.0	4.5	17.8	9.8	3.3	11.0	18.6	2.7	5.7	12.3	12.5	9.0	5.1	10.6	5.5	18.4	10.2	2.9	5.8	19.1	1.3	0.3	0.3	1.0	0.4	0.8	0.5	0.4	0.5	0.6	0.3	0.1	0.9	0.1	1.2	0.3	2.4	0.6	0.4	7.5	13.0	13.3	19.6	6.5	2.8	9.5	8.3	14.3	8.1
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 34.7;Karpas-707: 59.3;RPTEC TERT1: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1;neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nuclear membrane"	"Nucleoplasm, Vesicles"	"HPA047117: , HPA060198: "	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (3.33e-6)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	3.5	3.1	26.0	4.1	22.7	24.2	3.4	10.1	29.0	9.6	6.7	23.5	17.6	9.5	10.2	6.9	6.1	4.7	14.0	2.9	28.8	16.2	3.8	4.4	2.1	4.0	25.1	16.5	9.2	28.9	8.7	6.0	5.7	20.7	8.1	1.4	6.5	10.6	10.2	2.5	7.8	7.1	3.9	25.9	2.9	7.4	3.9	24.1	0.3	3.9	3.4	2.6	5.3	5.2	0.1	2.1	3.5	0.9	0.2	0.2	15.3	3.1	34.7	2.4	1.8	1.7	2.5	4.4	4.5	8.7	3.3	2.2	14.2	8.7	0.0	1.5	4.1	6.3	2.0	2.1	1.4	0.0	1.0	6.1	1.1	14.4	10.7	1.1	2.5	9.6	3.9	6.9	2.9	5.8	1.3	59.3	1.9	0.9	2.3	3.4	3.0	4.7	2.0	3.0	8.2	27.3	2.4	0.4	2.1	8.4	0.9	15.6	0.1	1.5	6.9	3.8	3.6	0.6	3.5	2.7	0.4	0.0	3.2	1.5	2.9	0.0	0.9	0.1	0.0	0.4	0.0	0.1	0.2	0.2	2.1	0.0	0.0	0.0	3.5	0.2	0.1	1.0	0.0	15.3	26.0	22.7	10.1	17.6	28.8	16.2	25.1	16.5	20.7	24.1
TEPSIN	"C17orf56, ENTHD2, FLJ31528"	ENSG00000167302	"TEPSIN, adaptor related protein complex 4 accessory protein"	Q96N21	17	81228277-81239091	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063410			Supported	"Nuclear membrane,Nuclear speckles,Golgi apparatus"				"Nuclear membrane, Nuclear speckles, Golgi apparatus"		"HPA063410: "	"unprognostic (6.90e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (9.96e-4)"	"unprognostic (1.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.29e-1)"	"prognostic favourable (6.95e-4)"	"unprognostic (4.99e-2)"	"prognostic unfavourable (7.31e-8)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.16e-3)"	8.5	6.7	8.0	11.9	8.5	17.3	21.3	11.9	9.8	6.0	9.9	9.0	7.3	14.9	7.9	8.6	8.8	8.0	6.6	4.9	8.8	4.7	9.8	13.3	12.5	13.5	12.5	6.3	6.8	11.1	5.3	9.2	7.7	9.8	10.1	6.5	4.8	9.1	9.3	12.4	15.8	12.4	9.8	8.5	17.0	9.7	9.1	9.8	12.2	12.6	7.5	9.0	7.2	7.0	3.0	2.7	7.6	2.9	0.7	1.8	1.2	8.7	12.9	5.0	8.1	3.5	5.8	10.0	7.8	4.4	7.8	7.2	8.3	6.2	6.3	4.4	5.2	11.4	5.2	6.6	3.8	3.8	17.1	5.2	7.2	11.9	5.2	5.6	10.9	3.0	8.6	3.6	4.1	12.4	6.4	6.2	5.0	7.6	10.5	13.0	5.5	11.1	6.6	6.6	6.9	3.0	5.6	6.7	7.8	9.3	10.2	10.7	6.9	10.1	7.9	10.6	6.1	8.1	7.4	8.4	5.8	4.7	7.8	4.8	5.2	4.2	2.4	7.6	1.8	2.9	1.1	2.5	1.2	1.4	2.7	3.0	0.8	0.8	4.3	0.7	1.9	2.7	1.6	1.2	8.0	8.5	11.9	9.8	8.8	4.7	12.5	6.3	9.8	9.8
TMEM205	"MBC3205, UNQ501"	ENSG00000105518	"Transmembrane protein 205"	Q6UW68	19	11342776-11346518	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Nucleoplasm, Nuclear membrane"	"HPA041504: AB_10795595"	"unprognostic (2.54e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.56e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	15.8	40.5	25.7	10.6	29.4	14.5	19.3	16.2	36.3	30.3	19.2	19.8	34.6	18.7	15.5	29.7	14.6	25.9	27.8	31.7	24.5	23.6	36.1	90.8	19.4	22.9	25.2	21.9	21.7	50.5	52.4	21.7	17.5	20.6	24.3	11.3	31.8	28.6	28.4	30.0	15.0	18.2	16.9	21.4	14.2	17.2	23.1	13.2	11.1	46.6	15.4	13.3	21.3	13.1	21.9	43.1	11.0	71.0	10.4	14.8	32.1	19.0	47.2	5.8	19.8	11.6	14.0	11.0	7.2	16.8	15.9	12.4	14.3	6.1	17.1	44.1	14.6	19.5	8.4	21.8	10.7	20.0	8.0	4.5	16.4	23.5	29.3	7.7	14.6	13.2	22.3	10.2	17.1	19.1	13.7	73.2	9.8	48.1	11.5	21.4	10.4	36.2	10.9	9.0	45.1	38.6	34.5	10.5	16.0	7.6	31.5	17.6	27.4	22.4	11.2	20.0	7.6	21.8	16.1	43.6	43.5	10.1	19.3	34.5	15.3	5.2	71.0	7.1	14.6	29.8	14.8	21.9	12.2	12.8	43.1	18.4	9.8	11.8	11.0	10.4	17.5	31.0	14.6	32.1	25.7	29.4	16.2	36.3	24.5	23.6	25.2	21.9	20.6	13.2
TMEM209	"FLJ14803, NET31"	ENSG00000146842	"Transmembrane protein 209"	Q96SK2	7	130164715-130207770	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031678	Uncertain		Approved	"Nuclear membrane,Nuclear speckles,Vesicles"				"Nuclear membrane, Nuclear speckles, Vesicles"		"HPA031678: AB_10603135"	"unprognostic (3.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.24e-1)"	12.0	33.5	9.9	9.1	12.1	9.4	12.2	12.7	13.3	9.4	12.2	23.8	9.5	10.4	16.4	11.8	8.8	11.2	8.1	7.9	9.9	10.9	11.6	16.9	10.3	12.2	11.6	12.0	13.7	19.8	19.0	18.7	18.6	16.4	10.3	12.9	19.0	16.5	10.3	10.1	11.1	19.0	10.5	19.1	13.3	8.8	17.8	11.3	24.9	18.6	8.0	13.1	11.1	8.9	14.1	10.8	10.0	13.4	13.8	20.5	10.4	9.4	9.1	12.4	15.3	7.2	7.4	9.2	8.6	8.7	7.9	10.6	10.1	17.2	14.0	6.5	5.5	14.2	14.5	10.0	14.1	17.3	8.3	7.3	15.4	6.7	12.8	15.3	7.4	8.2	10.3	15.7	15.7	6.0	23.5	16.5	9.5	12.3	29.1	9.3	18.5	8.1	15.7	13.9	23.2	7.9	12.1	11.1	17.1	19.7	31.7	12.5	10.2	10.3	4.7	14.4	5.6	15.0	20.7	22.0	32.2	29.2	23.4	17.7	22.1	10.0	8.9	9.5	17.0	13.4	17.7	14.1	17.4	15.4	8.6	14.0	20.5	17.3	1.3	13.8	11.3	10.8	17.3	10.4	9.9	12.1	12.7	13.3	9.9	10.9	11.6	12.0	16.4	11.3
TMEM223	MGC3196	ENSG00000168569	"Transmembrane protein 223"	A0PJW6	11	62771629-62792021	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"				"Nucleoplasm, Nuclear membrane, Mitochondria"		"HPA014504: AB_1853881"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.14e-3)"	"unprognostic (9.75e-2)"	10.9	20.6	12.8	13.4	19.5	8.7	11.6	11.1	25.5	11.7	15.2	13.4	12.0	16.6	12.7	15.5	12.3	11.9	11.8	21.7	12.6	12.8	19.5	20.4	10.5	16.2	12.4	15.6	12.5	38.7	10.4	13.0	10.9	13.2	14.8	11.6	13.9	22.4	15.0	21.3	16.2	18.2	8.4	11.1	16.1	16.2	8.2	11.6	19.0	13.4	10.6	14.2	11.1	10.2	32.4	28.0	8.9	16.6	23.1	30.7	15.3	15.1	12.9	7.7	10.6	6.2	7.1	10.6	8.2	7.1	9.2	7.7	11.3	18.6	11.4	20.1	5.8	23.1	9.3	10.1	5.3	18.0	17.5	8.4	14.6	13.4	11.5	10.3	10.0	7.7	10.2	6.0	7.6	7.0	12.8	8.5	6.8	22.0	10.3	23.0	15.3	15.7	12.9	9.4	25.3	14.2	9.7	13.3	17.6	8.5	17.4	21.5	26.0	9.7	7.4	11.1	13.4	10.1	9.7	17.6	14.0	13.0	13.1	9.3	11.5	7.3	16.1	8.9	28.4	16.6	27.2	28.2	28.1	27.6	17.5	32.4	30.7	29.8	7.5	23.1	10.5	28.0	23.9	15.3	12.8	19.5	11.1	25.5	12.6	12.8	12.4	15.6	13.2	11.6
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784635-114806126	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;kidney: 16.2;salivary gland: 28.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.5;hTEC/SVTERT24-B: 7.6;HUVEC TERT2: 14.5;RT4: 14.2;TIME: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"	1112540		"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA012948: AB_1858024, HPA046522: "	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	1.2	1.3	0.3	3.1	0.5	0.0	0.7	0.2	0.9	1.9	7.3	0.1	1.3	10.8	0.9	1.3	2.8	0.8	2.0	0.3	1.7	0.3	16.2	0.5	5.2	0.5	0.4	0.1	0.7	1.4	0.2	0.5	6.0	0.7	9.8	2.2	0.6	28.7	4.4	0.3	0.6	15.0	2.0	0.4	1.5	3.0	0.6	0.1	0.9	1.3	1.8	2.4	6.4	1.6	0.3	2.8	1.2	1.8	0.3	0.1	0.4	0.4	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.2	2.7	1.4	0.0	0.0	11.5	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	7.6	0.0	14.5	0.0	0.8	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0	0.0	0.7	0.0	1.1	0.0	6.6	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.8	0.1	0.1	1.8	0.0	0.3	0.1	0.0	2.8	0.3	0.1	0.1	1.2	0.3	0.2	1.5	0.0	0.4	0.3	0.5	0.2	0.9	1.7	0.3	0.4	0.1	0.7	0.1
TXNL4A	"DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD"	ENSG00000141759	"Thioredoxin like 4A"	P83876	18	79970811-80033949	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"		Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041324			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA041324: "	"unprognostic (7.56e-2)"	"unprognostic (1.06e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	28.2	35.8	57.2	27.7	43.9	36.7	30.2	21.7	43.4	22.0	29.4	30.7	22.9	23.9	15.8	38.9	26.5	21.0	21.8	33.5	47.9	42.7	29.0	42.5	18.4	35.1	52.6	25.4	14.1	64.9	22.1	38.4	23.2	32.7	21.1	25.2	24.0	46.8	20.5	35.5	26.6	25.1	19.0	37.7	26.9	23.2	41.6	20.8	40.2	28.8	26.8	32.2	23.5	16.9	12.7	25.0	8.4	9.6	11.3	12.7	4.4	21.5	29.0	25.9	24.6	21.2	22.4	23.0	23.5	19.0	31.9	29.0	27.0	15.4	26.3	8.8	22.4	18.4	31.1	27.3	21.1	30.7	39.5	18.9	44.1	63.4	27.1	54.0	30.9	20.8	24.2	22.7	29.1	30.0	16.5	38.4	22.2	39.0	38.3	36.6	20.2	63.0	23.4	17.3	54.2	31.3	34.2	39.7	28.9	11.6	34.6	42.8	17.0	32.2	14.1	28.2	34.6	12.8	28.6	17.1	64.0	43.2	26.4	41.1	25.8	8.4	8.4	6.8	12.2	9.6	8.4	12.3	10.0	9.6	11.4	12.7	10.2	11.9	6.8	11.3	9.5	25.0	12.7	4.4	57.2	43.9	21.7	43.4	47.9	42.7	52.6	25.4	32.7	20.8
UHRF1BP1	"C6orf107, dJ349A12.1, FLJ20302, ICBP90"	ENSG00000065060	"UHRF1 binding protein 1"	Q6BDS2	6	34792015-34883138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032099, HPA032100"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA032099: AB_10696057, HPA032100: AB_10671087"	"unprognostic (2.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (3.58e-2)"	"unprognostic (4.39e-3)"	"unprognostic (9.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.24e-2)"	7.6	9.3	7.6	7.6	8.2	18.7	6.7	18.5	10.9	4.8	5.9	7.1	4.7	5.1	5.5	4.4	6.0	5.3	4.5	13.7	6.1	5.8	6.1	10.9	8.0	6.9	5.5	6.8	6.6	13.1	15.1	9.5	8.1	7.7	6.0	6.3	6.8	8.6	5.1	22.2	4.9	5.5	6.4	7.6	6.8	7.2	22.5	5.5	8.5	9.4	3.2	6.8	5.9	10.8	1.5	1.2	1.1	4.5	1.4	1.3	0.8	8.3	6.0	5.4	17.4	2.8	2.1	9.7	4.9	3.3	4.8	6.8	11.9	2.2	12.6	5.4	5.1	6.4	19.5	2.8	6.6	6.5	6.3	11.2	5.8	9.9	11.6	10.1	7.0	4.7	8.2	3.8	8.2	6.0	18.7	5.0	2.1	8.0	7.8	6.6	2.4	4.2	4.7	8.6	7.6	6.5	7.8	6.5	6.6	12.4	6.5	16.6	12.4	13.3	3.7	2.4	8.8	3.7	5.4	7.5	11.7	8.1	1.3	14.2	5.9	0.5	1.2	1.1	1.3	1.7	1.3	1.3	1.2	1.3	1.2	1.5	0.6	1.0	0.7	1.4	4.5	0.5	0.4	0.8	7.6	8.2	18.5	10.9	6.1	5.8	5.5	6.8	7.7	5.5
UTP18	"CGI-48, WDR50"	ENSG00000011260	"UTP18, small subunit processome component"	Q9Y5J1	17	51260528-51297936	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052378	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoli	"Nucleoplasm, Nuclear membrane"	"HPA052378: "	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (3.33e-4)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (2.47e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.93e-2)"	15.6	16.1	14.4	18.0	20.5	26.9	20.2	23.3	20.9	15.0	13.6	14.5	12.4	13.6	13.0	13.4	17.7	14.0	11.1	8.9	14.2	13.9	17.1	16.9	14.0	22.9	17.0	20.5	19.4	18.1	17.3	19.4	28.3	16.1	13.1	15.0	12.8	14.9	11.9	19.1	25.7	13.0	10.2	14.4	22.0	13.5	42.5	16.9	21.6	19.1	15.6	25.3	15.2	17.9	26.1	26.4	12.4	22.9	17.4	28.1	24.9	26.3	26.2	16.7	15.3	11.0	16.6	43.7	14.6	12.1	25.6	24.7	16.4	14.8	33.5	20.9	10.9	14.4	27.1	15.6	38.2	21.8	35.3	35.1	15.9	28.5	15.1	37.1	17.3	10.6	12.1	21.7	17.7	15.3	28.5	15.4	19.2	16.3	33.3	25.3	23.9	27.8	30.3	38.1	26.2	18.7	17.6	18.6	23.7	17.0	20.3	33.1	25.0	19.0	13.3	26.5	22.2	21.7	30.3	29.9	55.1	38.8	16.4	25.9	18.8	6.8	22.9	12.4	20.5	21.6	24.9	26.1	25.8	24.7	26.4	24.4	28.1	26.2	4.0	17.4	21.1	16.6	25.7	24.9	14.4	20.5	23.3	20.9	14.2	13.9	17.0	20.5	16.1	16.9
YTHDF3	FLJ31657	ENSG00000185728	"YTH N6-methyladenosine RNA binding protein 3"	Q7Z739	8	63168553-63212786	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048703			Approved	"Nuclear membrane,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear membrane, Cytosol"	"HPA048703: "	"unprognostic (1.06e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.65e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.11e-1)"	21.7	17.5	12.2	12.8	15.2	53.2	16.0	16.7	17.3	19.4	20.2	14.3	16.8	14.2	24.3	13.6	17.7	17.6	17.6	26.9	11.9	11.4	18.8	26.8	16.8	12.4	14.2	10.6	25.1	15.6	16.6	19.3	29.0	16.8	21.2	15.6	12.9	18.1	18.8	28.0	12.7	24.7	19.4	14.4	18.1	15.9	13.3	14.2	20.1	17.2	15.9	14.1	21.0	15.9	8.2	16.9	21.2	24.9	9.7	11.0	10.1	16.0	21.8	21.0	15.8	28.1	24.2	14.4	29.3	24.6	18.6	22.1	18.5	16.1	17.0	6.4	28.5	15.4	27.6	19.5	27.7	13.8	13.1	31.6	16.5	12.5	25.6	9.0	15.6	32.0	15.0	19.9	27.9	15.7	18.5	15.6	27.9	11.1	17.2	8.4	29.2	16.1	13.1	16.1	8.4	17.5	28.5	8.6	15.4	20.8	18.8	21.2	25.2	11.4	28.2	17.4	16.8	15.5	15.7	18.8	17.0	25.5	17.7	12.7	20.9	20.6	16.6	17.4	8.9	19.4	9.8	7.4	9.0	10.5	16.9	8.2	11.0	10.5	21.2	9.7	24.9	5.1	9.4	10.1	12.2	15.2	16.7	17.3	11.9	11.4	14.2	10.6	16.8	14.2
ZBED1	"ALTE, DREF, hDREF, KIAA0785, TRAMP"	ENSG00000214717	"Zinc finger BED-type containing 1"	O96006	X	2486414-2500967	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA077591			Approved	"Nucleoplasm,Nuclear membrane,Centrosome"				Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA077591: "	"unprognostic (7.66e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.27e-1)"	8.5	10.5	24.8	6.0	30.7	3.1	63.7	24.8	29.0	36.8	8.1	1.7	1.7	10.6	28.9	2.8	6.1	6.4	7.1	43.4	27.3	7.2	39.6	13.6	5.9	6.0	25.1	19.6	28.7	10.4	6.8	27.8	37.5	32.5	6.8	6.4	1.7	7.7	6.3	29.5	9.5	11.2	5.1	30.4	7.9	6.6	3.4	27.1	1.7	5.4	1.7	4.8	5.8	31.4	12.7	13.7	13.0	12.4	5.4	11.5	10.2	5.1	12.9	9.4	10.3	6.0	6.4	42.5	7.3	8.1	4.3	5.0	16.4	4.6	10.2	8.5	9.7	2.4	8.9	7.6	3.2	12.0	11.9	7.6	11.0	13.9	7.9	4.6	15.9	9.4	6.0	4.5	3.4	10.2	9.6	3.4	8.4	3.6	7.7	3.7	23.1	7.6	6.2	9.3	4.8	7.2	10.1	11.2	11.0	6.2	16.8	11.6	4.6	10.0	13.9	9.3	4.9	5.1	7.9	4.1	0.0	16.9	3.8	6.7	5.2	1.8	11.6	9.7	11.5	12.4	10.3	9.4	6.8	6.5	13.7	12.7	6.6	5.4	13.0	5.4	9.3	10.1	6.6	10.2	24.8	30.7	24.8	29.0	27.3	7.2	25.1	19.6	32.5	27.1
ZBTB41	"DKFZp686C06120, FLJ36199, FRBZ1, ZNF924"	ENSG00000177888	"Zinc finger and BTB domain containing 41"	Q5SVQ8	1	197153680-197200542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034841, HPA034842"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA034841: , HPA034842: AB_10669995"	"unprognostic (2.36e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.01e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavourable (5.86e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.58e-1)"	2.6	3.8	4.1	1.8	4.0	0.2	5.9	10.8	5.0	4.5	2.2			2.1	3.2	3.8	2.4	2.8	3.2	2.3	4.0	4.7	4.3	3.3	2.3	2.4	4.2		5.9	2.9	5.6	3.8	2.2		3.3	2.5		2.9	2.6	3.3	2.4	1.8	2.2	4.8	3.0	3.2	2.6			6.4		2.2	3.1	2.1	1.5	1.4	1.7	0.7	1.8	2.2	0.7	7.2	4.1	5.5	4.4	8.7	13.2	4.4	4.4	7.3	4.7	4.4	2.6	6.1	2.7	6.4	10.0	6.0	3.8	3.8	7.4	2.3	2.2	2.2	5.5	2.4	7.7	4.3	2.1	5.4	10.1	4.7	8.2	3.1	5.0	3.3	11.9	3.5	3.2	2.4	2.1	1.5	2.2	7.6	4.8	5.7	4.1	7.8	6.9	7.9	13.9	8.3	10.6	3.3	5.2	9.2	5.4	7.2	5.7	3.7	1.9	2.9	4.3	1.6	12.7	1.7	0.7	0.4	1.2	0.4	2.2	1.5	1.6	1.6	1.4	1.4	2.2	2.0	0.0	1.8	0.6	0.7	1.0	0.7										
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type containing 16"	Q969W1	10	97446131-97457370	"Enzymes, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	12.0	13.7	15.9	10.8	17.3	6.4	17.9	17.6	24.6	17.1	17.9	15.6	18.1	15.1	15.5	21.2	17.6	11.5	14.4	18.1	13.2	11.0	23.3	37.4	20.8	11.1	10.9	13.0	15.1	22.5	21.8	15.4	30.7	10.5	16.0	18.9	18.1	28.5	14.1	20.7	14.0	15.7	17.6	8.5	13.2	19.4	16.4	10.8	14.7	19.6	15.4	16.1	15.1	20.0	9.3	14.2	9.4	10.4	13.0	12.0	5.8	21.4	25.2	16.8	20.7	26.9	18.5	17.6	23.6	31.5	27.3	26.1	19.6	19.2	18.9	27.3	34.5	25.3	21.1	33.4	24.4	18.7	24.5	12.0	17.7	18.6	21.6	14.3	17.7	20.6	22.1	31.9	23.0	28.0	9.6	14.4	34.5	20.5	21.6	19.6	13.7	21.9	14.8	17.1	17.4	23.1	9.9	8.2	11.7	14.4	14.9	12.8	19.7	14.0	17.1	17.2	16.0	11.1	27.6	13.8	22.3	11.6	19.9	22.2	9.0	0.3	9.8	9.4	7.0	10.4	8.0	8.2	12.0	11.1	14.2	9.3	9.9	9.8	0.5	13.0	10.4	10.9	9.4	5.8	15.9	17.3	17.6	24.6	13.2	11.0	10.9	13.0	10.5	10.8
ZFP82	"KIAA1948, MGC45380, ZNF545"	ENSG00000181007	"ZFP82 zinc finger protein"	Q8N141	19	36383120-36418656	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051669, HPA060470"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA051669: , HPA060470: "	"unprognostic (1.52e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.14e-4)"	"unprognostic (9.63e-2)"	"unprognostic (9.17e-4)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.91e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.05e-1)"	4.3	5.0	9.8	8.8	9.3	1.5	8.7	15.0	13.9	9.9	5.2	5.3	2.4	2.4	9.1	12.4	2.7	9.0	5.4	7.3	8.5	9.7	5.5	1.8	4.9	7.8	8.3	6.3	13.8	2.7	8.0	10.1	7.0	8.3	7.4	3.3	3.6	4.1	6.8	2.1	2.2	3.6	7.8	6.8	6.3	3.1	6.4	8.7	9.3	10.8	1.6	8.6	5.8	6.9	9.6	3.1	1.1	1.1	4.7	9.2	2.9	0.0	2.6	8.4	8.8	2.9	3.8	2.8	3.4	4.3	7.0	9.1	1.6	1.2	7.4	5.8	4.1	0.2	0.0	0.9	8.9	6.9	4.2	6.6	1.9	2.1	6.7	0.0	5.8	5.8	1.3	5.0	1.5	3.2	0.0	0.0	6.8	0.0	11.5	0.0	7.9	1.5	9.7	5.8	2.2	3.5	4.2	0.1	8.7	0.0	0.5	5.5	1.6	5.1	0.4	2.5	4.4	4.5	5.8	5.1	3.5	11.4	0.0	0.0	5.4	0.0	0.9	1.1	6.0	1.1	6.0	9.6	5.9	6.8	2.7	9.0	9.2	8.1	0.1	4.7	1.1	3.1	3.6	2.9	9.8	9.3	15.0	13.9	8.5	9.7	8.3	6.3	8.3	8.7
ZNF324	"ZF5128, ZNF324A"	ENSG00000083812	"Zinc finger protein 324"	O75467	19	58467045-58475436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA039774	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA039774: AB_10673149"	"unprognostic (8.60e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (4.74e-5)"	"unprognostic (6.39e-2)"	"prognostic favourable (1.34e-7)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (3.56e-1)"	7.7	8.0	8.9	11.5	10.8	12.6	7.4	15.8	14.0	9.8	8.8	11.9	10.2	8.5	12.0	9.1	12.7	10.5	9.2	7.6	9.9	9.3	6.5	10.5	7.7	10.5	10.4	11.5	14.6	15.0	10.2	12.7	7.1	7.1	10.6	6.0	7.2	11.2	13.3	5.8	11.9	7.3	8.2	9.3	8.3	8.6	8.0	9.7	16.8	11.9	8.1	10.7	9.3	7.2	6.4	6.4	13.1	5.0	6.0	11.8	3.4	4.0	5.1	3.5	5.3	4.0	3.5	3.8	3.3	4.1	3.3	3.0	4.5	2.0	6.3	3.1	2.7	5.1	4.5	4.5	1.6	5.5	34.8	4.4	3.9	2.1	3.2	7.3	5.2	2.6	5.6	4.7	2.2	2.3	6.2	4.1	3.6	3.3	6.5	4.0	2.8	7.8	7.0	4.4	4.0	2.4	8.2	7.1	5.6	3.6	5.8	2.5	2.9	5.3	4.1	10.0	2.2	3.5	5.6	6.0	6.0	3.2	5.0	3.6	3.1	2.3	4.7	7.2	9.5	5.0	10.7	5.3	7.6	10.5	3.2	6.4	11.8	8.9	13.1	6.0	3.9	6.4	7.2	3.4	8.9	10.8	15.8	14.0	9.9	9.3	10.4	11.5	7.1	9.7
ZNF484	"BA526D8.4, FLJ33884"	ENSG00000127081	"Zinc finger protein 484"	Q5JVG2	9	92845031-92878038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA028973	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028973: AB_10610703"	"unprognostic (5.52e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.84e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.77e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.51e-1)"	6.5	6.6	9.9	5.4	14.6	10.1	6.5	33.0	13.9	7.7	4.8	7.8	4.7	3.7	7.0	5.3	4.2	6.2	4.7	4.9	11.7	7.0	7.3	5.2	5.8	6.6	12.5	7.1	9.1	4.5	12.1	14.0	7.9	12.6	7.0	5.2	4.6	5.0	6.3	3.7	4.2	5.0	6.2	17.1	7.7	6.0	4.8	13.5	2.8	9.0	1.9	7.9	7.3	5.8	5.6	2.5	5.3	3.5	4.5	7.4	3.0	4.0	5.0	6.6	4.2	3.4	4.2	0.0	3.3	5.4	6.0	6.5	1.6	3.1	3.5	3.0	2.7	6.7	4.8	5.0	6.3	5.6	2.1	3.0	4.0	3.3	5.3	2.5	5.5	4.7	3.8	6.5	6.9	5.1	3.2	14.2	6.4	4.1	3.6	1.1	5.4	2.5	3.0	8.0	2.6	3.2	4.6	4.6	4.1	5.9	1.7	3.3	0.4	2.0	5.5	5.4	5.1	2.8	2.4	5.4	2.7	2.1	3.5	2.0	4.2	1.4	2.5	5.3	5.3	3.5	6.5	3.7	5.4	4.4	2.2	5.6	7.4	6.7	1.4	4.5	3.1	2.5	4.4	3.0	9.9	14.6	33.0	13.9	11.7	7.0	12.5	7.1	12.6	13.5
ZNF487	"KRBO1, ZNF487P"	ENSG00000243660	"Zinc finger protein 487"	B1APH4	10	43436841-43483179	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 32.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA037820			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA037820: AB_10697083"	"unprognostic (1.97e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.97e-4)"	"unprognostic (5.85e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.92e-2)"	4.1	2.7	4.8	2.7	5.3	5.1	3.9	11.1	9.1	4.6	3.5	3.3	2.2	3.3	5.1	3.1	2.8	7.9	4.9	3.2	6.6	5.0	3.3	3.1	4.0	2.9	5.6	7.4	6.1	2.3	3.7	6.9	2.6	11.2	3.3	2.7	4.0	2.5	4.0	1.7	3.3	3.5	4.2	8.1	3.1	3.0	32.1	6.4	4.3	4.4	2.0	2.9	4.3	3.4	3.2	5.1	13.9	3.9	3.5	4.7	2.6	2.4	2.3	2.9	3.0	3.6	7.2	0.7	4.0	6.9	3.7	4.0	3.6	6.6	6.2	0.7	4.7	3.9	0.9	1.5	4.6	0.6	1.5	1.9	0.6	2.0	4.5	1.9	2.8	7.2	3.4	6.0	4.6	1.3	1.0	1.2	2.7	4.1	3.9	1.6	0.8	2.5	2.0	1.0	2.4	8.3	2.6	2.8	1.9	3.4	2.0	2.2	3.1	2.3	2.0	3.4	2.4	1.9	1.1	0.5	1.6	6.7	8.2	2.7	1.3	2.5	3.9	5.8	4.7	2.8	4.0	2.8	3.5	4.3	5.1	3.2	3.0	3.6	13.9	3.5	1.5	3.9	1.8	2.6	4.8	5.3	11.1	9.1	6.6	5.0	5.6	7.4	11.2	6.4
ZNF626		ENSG00000188171	"Zinc finger protein 626"	Q68DY1	19	20620061-20661596	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA045631	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA045631: "	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.31e-1)"	8.1	13.9	10.2	6.0	15.6	4.1	18.5	15.2	14.8	11.2	8.3	12.0	21.6	2.4	13.0	9.5	8.0	14.0	10.7	10.8	10.1	10.1	12.7	6.5	7.2	12.4	10.9	11.1	29.2	9.6	36.3	14.8	8.3	11.0	12.8	4.4	13.6	8.9	23.9	7.3	10.8	6.0	11.9	12.1	7.8	9.1	5.8	11.9	13.6	26.9	4.9	10.7	21.3	9.7	11.4	4.2	11.6	4.3	9.1	8.6	4.2	0.1	0.0	4.3	0.7	5.3	6.9	0.5	4.9	0.5	7.0	6.2	0.2	0.2	0.7	2.5	6.0	0.8	0.0	0.2	8.9	0.0	0.2	0.0	0.1	1.7	9.4	0.1	0.1	12.8	2.2	4.1	2.2	3.3	3.0	0.5	7.3	0.1	0.8	1.1	9.3	2.2	4.3	3.2	1.6	7.0	5.3	1.5	8.3	0.2	0.5	4.4	10.3	0.4	0.0	3.2	0.2	12.7	0.5	6.9	13.8	6.2	0.1	0.1	0.5	0.8	1.1	6.0	7.6	1.0	7.3	7.9	8.0	8.6	3.2	11.4	7.7	6.6	11.6	9.1	4.3	4.2	3.7	4.2	10.2	15.6	15.2	14.8	10.1	10.1	10.9	11.1	11.0	11.9